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NONCONTACT THREE-DIMENSIONAL
DIFFUSE OPTICAL IMAGING OF DEEP
TISSUE BLOOD FLOW DISTRIBUTION
RELATED APPLICATIONS
This application claims priority to U.S. Provisional Appli
cation 62/136,707, filed Mar. 23, 2015, which is hereby
incorporated by reference in its entirety.

10

GOVERNMENT SUPPORT
This invention was made with govermnent support under
grants R21-AR062356 and UL-1RR033173 Pilot Grant
awarded by the National Institutes of Health. The govern 15
ment may have certain rights in the invention.
FIELD OF THE INVENTION
The present invention relates to the application of diffuse 20
correlation tomography (DCT) through both noncontact
(ncDCT) and charge-coupled-device (CCD)-based noncon
tact speckle contrast (nc_scDCT) approaches for three
dimensional (3-D) reflectance imaging of deep tissue (up to
1.5 cm depth) to better assess any potential tissue injury 25
therein.
BACKGROUND
The ability to image within diseased or sensitive tissue is
highly desirable as it provides further information as to the
underlying health of the tissue, but remains problematic in
successful execution due to accessing the tissue without
touching the surface. Significant problems with contact
measurements (using a probe in contact with tissue) include
the risk for infection of vulnerable tissues (e.g., wounds,
bums, reconstructive tissue flaps) and the deformation of
soft tissues (e.g., breasts) distorting blood flow and oxygenation.
Chronic wounds affect over 5 million Americans each
year, resulting in over $20 billion in health care costs.
Individuals with disabilities and diabetes as well as the
elderly have the highest risk of developing chronic wounds.
Patients afflicted with chronic wounds suffer from physical
pain and disabilities in addition to psychological and emo
tional stresses and poor quality of life. Current treatments for
chronic wounds include cleansing, debridement, maintain
ing a moist tissue environment, and when possible, elimi
nating the underlying pathology or factors that contributed
to poor wound healing. In advanced cases, amputation may
become necessary. Death, especially in elderly patients, may
result from sepsis that can be associated with chronic
wounds. Multiple factors can lead to impaired wound heal
ing. Local factors that influence healing include tissue blood
flow and oxygenation. Pressure ulceration, For example,
occurs when the skin and underlying tissues are compressed
for a period of time between the bone and the surface on
which the patient is sitting or lying. Constant pressure
against the tissue reduces blood supply to that area which
results in tissue ischemia1 • 2. Ultrasound imaging results
have recently shown that early pressure ulcers originate
from deep tissues attached to the bone and spread upwards,
eventually to the skin3. Therefore, quantification of blood
flow in deep wound tissues is crucial for accurate diagnosis
and treatment monitoring.
As another example of tissue injury, a burn is damage to
body's tissues caused by heat, chemicals, electricity, sun-
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light or radiation. Bums can cause swelling, blistering,
scarring and, in serious cases, shock and even death. They
also can lead to infections because they damage skin's
protective barrier. Treatment for bums depends on the cause
of the bum, how deep it is, and how much of the body it
covers. Antibiotic creams can prevent or treat infections. For
more serious burns, treatment may be needed to clean the
wound, replace the skin, and make sure the patient has
enough fluids, nutrition, blood flow, and tissue oxygen.
As a further example, mastectomy skin flap necrosis may
ultimately lead to implant exposure, infection and implant
loss. In some of these cases, the complications may be so
devastating as to cause a failure of reconstruction4•5 •6. Of the
75,000 expander-implant based reconstructions performed
in 2013, more than 18,000 resulted in implant loss, second
ary to complications7. The cost of implant loss alone is
>$30,000 8, plus the fees incurred by additional operating
room time, clinic visits, inpatient stays, surgeon costs and
procedure fees.
Similarly, head and neck cancer accounts for 3 to 5% of
all cancers in the United States9. Despite all the advances in
non-surgical treatments, surgery remains an important tool
in the management of these cancers. Primary or salvage
surgeries are extensive and often lead to major head and
neck defects that require complex reconstructions with local
flaps, regional flaps, or free tissue transfer flaps. Intraopera
tive decreases in blood flow after flap anastomosis have been
observed1 0•11, which may lead to failure of flap thrombosis.
Thus, knowledge of tissue blood flow changes after tissue
transfer may enable surgeons to predict the failure of flap
thrombosis at an early stage to salvage ischemic flaps.
Current imaging diagnostic tools include x-ray computed
tomography (CT), magnetic resonance imaging (MRI), posi
tron emission tomography (PET) and ultrasonography, but
most of these imaging methods are prohibitively expensive
and generally only provide tissue morphological informa
tion. Moreover, some of these techniques (e.g., CT and PET)
expose patients to ionizing radiation12 •13. Doppler ultrasound is limited in measuring only blood flow in large
vessels.
Often, the surface of a tissue does not provide sufficient
feedback as to the health of the tissue within. For example,
when flap ischemia is a concern, most surgeons rely primar
ily on careful and frequent visual examination of the flap
surface. Several tools and techniques are currently in use to
monitor flaps in order to detect changes in viability in a time
frame that allows for salvage of the flap from its nonviable
state. While transcutaneous or implantable ultrasound Dop
pler technologies are commonly used to assess blood flow
through large axial vessels, peripheral flap blood flow
remains largely subjective in its clinical assessment 11 •27-29.
Laser Doppler technique has also been used to monitor
blood flow at a tiny spot of superficial tissue, which may not
reflect precisely hemodynamic changes in the bulk flap
tissue1 0•30•31 . The ischemia and hypo-perfusion that can
occur intra-operatively in the flap are often not evident to the
surgeons until days/weeks later when it presents as skin flap
necrosis. Therefore, clinical assessment alone is not reliable.
For example, mastectomy skin flap necrosis, infection and
implant loss are all interlinked by a shortfall of perfusion and
tissue oxygen at the microcirculatory level. Previously, a
prospective clinical trial of tissue expander-implant breast
reconstruction has been conducted with intraoperative
evaluation of mastectomy skin flaps by clinical assessment,
laser-assisted indocyanine green dye angiography, and fluo
rescein dye angiography32. Due to the requirement of an
intravenous injection, these methods lack feasibility for
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continuous use in clinical preoperative and postoperative
settings; and they are time-dependent, requiring evaluation
after a particular time period following dye injection. Thus,
noninvasive, continuous, and quantitative imaging methods
are highly advantageous to assess tissue hemodynamic states
and alterations for perioperative management flap ischemia
to reduce the likelihood of postoperative ischemic compli
cations.
Near-infrared (NIR: 650 nm to 900 nm) diffuse optical
technologies provide a noninvasive and relatively inexpen
sive tool for functional imaging of tissue hemodynamics in
deep microvasculature up to several centimeters 14- 1 7. The
most commonly used NIR diffuse optical spectroscopy/
tomography (DOS/DOT) can currently quantify tissue
hemoglobin concentration and blood oxygen saturation.
Traditional DOS/DOT using the fiber-optic interface has
been used over several decades to detect distribution of
oxygenation alternations in tissues 18-22 .
A relatively new NIR diffuse correlation spectroscopy
(DCS) technique has been also developed for direct measurement of blood flow in deep tissues (up to -1.5 cm)2 3•24.
DCS employs coherent NIR light to probe deep tissues and
single-photon-counting avalanche photodiodes (APDs) to
detect temporal speckle fluctuations of the diffuse light on
tissue boundaries. Long-coherence lasers and APD detectors
are connected with optical fibers placed on the tissue bound
ary for DCS measurements. The measured temporal speckle
fluctuation depends on the motion of moving scatterers
(primarily red blood cells in the microvasculature), which is
related to a blood flow index (BFI). BFI can be quantified by
iteratively fitting the measured light intensity autocorrela
tion function.
Despite advances in DCS technologies, there have been
limited imaging applications of diffuse correlation tomog
raphy (DCT). A probe-tissue contact based DCS/DCT
approach has been described, but as with other approaches
it remains disadvantaged in vivo due in part to compression
induced hemodynamic alterations or potential infections on
ulcerous tissues. Another limitation lies in their reliance on
analytical solutions that assumed a simple semi-infinite flat
tissue geometry. Thus, an approach without the request of
contact measurement may address these limitations.
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SUMMARY OF THE INVENTION
The present invention provides systems and methods for
three-dimensional (3-D) reflectance imaging of blood flow
distribution in deep tissue. The systems offer an approach
that avoids contact with the subject being imaged, thereby
offering systems that allow for imaging of sensitive, supple
or diseased tissue. The imaging can be achieved of depths of
1.5 cm or less. The systems and methods provide for
projecting and focusing an imaging probe on to a tissue
surface of a subject. The imaging probe may comprise
source fibers connected to long-coherence lasers that emit
near-infrared (NIR) light. The systems and methods further
comprise a detector array also projected and focused on the
tissue. The imaging probe may then apply beams of NIR
light through a set of optical lenses to the tissue and the
detector array to detect the diffused NIR light from the tissue
through a second set of optical lenses. An image may then
be constructed based on measured diffused near-infrared
light transporting from the source fibers through the tissue to
the detector array.
The systems and methods provide in part for the detector
array to be at least one linear array of photodiodes. In other
parts, the detector array may comprise a two-dimensional
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(2-D) array of photodiodes. In yet further parts, the detector
array may comprise a 2-D array detectors provided by a
charge-coupled-device (CCD). In instances where the detector array is linear, coupling the imaging probe to a motorized
stage allows the probe to be systematically and automati
cally moved across a region of interest of the tissue.
In aspects where the detector array comprises a 2-D CCD,
the NIR light can be applied through at least four source
fibers to borders of a region of interest of a tissue of a subject
with the CCD detecting near-infrared diffused light through
an optical lens coupled to a CCD. Contact with the subject
can be avoided by either connecting the source fibers with
optical lenses or by applying the light through a Galva
m!fror.
The present invention also provides in part for computing
systems to construct a 3-D flow image from collected data.
The computing systems may execute a finite-element
method (FEM) based facilitation of detected unnormalized
electric field autocorrelation function, G i (r;t)=( E(r, t)E*(r,
t+i:)), by applying the data set to an adapted correlation
diffusion equation of V·((D�f)/';)VG i (r;t))-(µa(r)+1hµ)(r)
k/a( llr2 (t)))G 1 (r;t)=-S(r)e' =d.) where r is the position
vector and v is the light speed in the medium. µa(r) is the
medium absorption coefficient, and D(r)ssv/3µ',(r) is the
medium photon diffusion coefficient, µ)(r) is the medium
reduced scattering coefficient, -i: is autocorrelation delay
time, c is speed of light in vacuum, and A is wavelength and
(r,)= 1/3µ)(r)k02 a( llr(-i:)) as a dynamic absorption with k 0 as
the wave number of an incident light field, a is the unitless
ratio of dynamic scatterers to total (dynamic and static)
scatterers. ( llr2 (-i:)) is the mean-square displacement in time
-i: of the moving scattering particles (e.g., red blood cells);
for the case of diffuse motion, ( llr(-i:))=6DB(r)-i: where DB
(r) (unit: cm2/s) is an effective diffusion coefficient of the
moving scatterers; and then redefining µad(r,-i:)=2µ)(r)
k/aDB(r)-i: then extracting aDB(r) as blood flow index that
can collectively be compiled with multiple blood flow
indices measured at difference source-detector (S-D) pairs to
construct an image. In instances where an obtained data set
may comprise a measured spatial speckled contrast K (such
as by a CCD), these data may be first converted to a blood
flow index across each of S-D pair prior to extracting
aDB(r). Such can be accomplished by relating K to the
normalized temporal autocorrelation function g 1 by K2 =2�/
2
Tf0r(l--i:/T)[g 1 (r,-i:)] d-i:,
where � relates detector and speckle size. This is then
followed by identifying a nonlinear relationship by K2 =f
(aDB,T,µa ,µ),A,�,S-D,k0 ),
and, finally minimizing (K2-f)2 to obtain the blood flow
index.
The present invention also provides in part for creating a
3D solid model of the tissue being imaged by first acquiring
autocorrelation functions at each measurement location of
the S-D array; and then acquiring a surface geometry of the
tissue with a 3-D camera that includes the boundaries of the
region of interest. Following such, a solid tissue model may
be created with arbitrary surface from the captured surface
image with a 3-D CAD enabled alignment system. On the
tissue model, the sources and detectors from the S-D array
on the model can then be aligned which allows for 3-D
reconstruction of blood flow index distribution from auto
correlation function measurements.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows (a) the custom-made noncontact diffuse
correlation spectroscopy (ncDCS) system including (1) a
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noncontact optical probe, (2) a linear motorized stage, (3) a
multiple-axis stand holder, (4) a laptop control panel, and (5)
a ncDCS device and (b) the front view of ncDCS device.
FIG. 2 shows (a) the mechanical configuration and (b)
optical paths of ncDCS probe. The source and detector fibers
are innovatively projected through separated lens paths onto
the tissue surface, which avoids cross-talk between light
delivery and detection.
FIG. 3 shows schematic diagram of a noncontact diffuse
correlation tomography (ncDCT) with rotational scanning
system. (a) A motorized rotational stage was used to
remotely scan over a representative region of interest (ROI)
on a breast. A laser pointer was used to align the rotation axis
approximately through the nipple. The relative position
between the ncDCT probe and ROI (i.e., working distance,
initial step of scanning) can be adjusted manually by the
linear stage and the rotational platform. (b) Fifteen single
mode detector fibers connected with A PDs were equally
arranged in a 7 mm line to cover a 20 mm range through the
magnification of lenses. (c) The source and detector fibers
were projected on the breast surface using achromatic
lenses. Two source paths projecting two coherent NIR lasers
(785 nm) were attached to the sides of the detector path.
FIG. 4 shows an illustration of (a) the ncDCT focusing
apparatus with photon projections to and from a sample, (b)
linear array of single-mode detector fibers, (c) motorized
linear scanning staging over a representative ROI, and (d)
the pump-connected cylindrical tube-shaped anomaly in a
tank filled with Intralipid liquid solution.
FIG. 5 shows the setup for testing a charge-coupled
device (CCD)-based speckle contrast diffuse correlation
tomography (scDCT) system for 3-D flow imaging. (a) The
CCD is focused onto a liquid phantom surface. A square
metal holder positioned four fibers supporting their ferrule
tips on the liquid surface. The holder provided a 2.4 cmx2.4
cm open area. The optical switch distributed laser light into
the four source fibers sequentially. (b) Configuration of the
four sources, CCD field of view (FOY), solid phantom
placement, and detector area.
FIG. 6 shows a CCD-based fully noncontact scDCT
(nc_scDCT) system using separated sources (a) or Gavano
mirror (b) based sources for imaging of flow contrast. (c) A
typical source-detector distribution pattern.
FIG. 7 shows the protocol for perioperative blood flow
monitoring during free tissue transfer measured by ncDCS:
(a) intraoperative measurement on the elevated flap; (b)
intraoperative measurement on the flap after anastomosis
through mouth cavity; (c) postoperative measurement on the
transferred flap.
FIG. 8 shows the flow variations at the four different S-D
separations (10.0, 15.7, 22.8, 30.0 mm) measured by ncDCS
on the (a)-(d) liquid phantom and (e)-(h) healthy forearm
over seven days. The error bars represent the standard
deviations over the 2-min measurements.
FIG. 9 shows the blood flow variations (rBF) measured by
ncDCS at (a)-(d) four S-D separations in one successful case
(case 1) and (e)-(h) the unsuccessful case during the opera
tion and at postoperative days 2, 4, 7 ( data are not available
at postoperative day 7 for the unsuccessful case). "E"
represents the time point when the flap is raised. Day "O"
represents -30 min after flap anastomosis, which is used as
the baseline for normalization. Error bars represent standard
deviations over the 2-min time course data.
FIG. 10 shows Averaged rBF data measured by ncDCS at
four S-D separations in all successful cases over seven days.
Error bars represent standard errors over subjects.
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FIG. 11 shows the rBF data measured by ncDCS from all
flap cases (cases 1 to 8) including the unsuccessful one (case
8) highlighted with large hexagrams. Note that data from the
unsuccessful case (case 8) at day 7 are not available due to
the subsequent re-flap before that day. The error bars (see
FIG. 13) for individual cases are not shown for clarity
FIG. 12 shows the comparison of rBF changes measured
by ncDCS between the successful and unsuccessful flaps.
Averaged rBF values over the seven successful cases during
operation and on postoperative days 2, 4, 7 are presented as
mean standard errors (error bars represent the variations
over seven cases). rBF from the unsuccessful flap (case 8)
was measured at the time of flap elevation and on postop
erative days 2 and 4.
FIG. 13 shows results of computer simulations and phan
tom experiments measured by ncDCT on a homogeneous
slab background and internally placed tube-shaped anomaly
of varied flow contrast. The reconstructed anomaly from the
last step with highest flow contrast is shown (a) 3-D overlaid
on the assigned anomaly and two-dimensional (2-D) cross
section views (x, y, z) in the simulation and (c) in the
phantom experiment. Both (b) and (d) show a linear rela
tionship between the assigned anomaly and reconstructed
flow indices expressed as ratios of relative changes respec
tively in the simulation and phantom experiment.
FIG. 14 shows a 3-D camera to obtain surface images of
the breast and reference plane (RP) for ncDCT image
reconstruction. (a) The breast surface with source marks was
imaged by the 3-D camera. An "imaging region" C-5"x5"),
displayed in the inset, was selected inside the FOY for
generating the solid breast model (see FIG. 32). (b) After the
mannequin was removed, a small foam pad was attached to
the ncDCT scanner. The 3-D camera took another image to
include the small foam pad whose surface (RP) was adjusted
perpendicularly to the rotation axis. The RP was used for the
coregistration of two coordinate systems: 3-D camera and
ncDCT.
FIG. 15 shows procedures converting the acquired breast
surface to a solid breast model for ncDCT image reconstruction. (a) The mannequin breast surface with source marks
and the reference plane (RP) were integrated into one image.
The three pairs of source marks and the rotation center mark
can be clearly seen. (b) A bottom plane (BP) parallel to the
RP was created and a 3-D solid breast model was then
generated by extruding the 2-D contour on BP along the
rotation axis to the 3D breast surface.
FIG. 16 shows coregistration procedures to place the solid
breast model obtained in 3-D camera coordinate system
(left) into the ncDCT coordinate system (right). The rotation
center of the ncDCT probe obtained by the 3-D camera (left)
was placed at (0, 0, 50 mm) in the ncDCT coordinate system
(right).
FIG. 17 shows alignment of sources and detectors of
ncDCT on the surface of the solid breast model. (a) A
scanning plane (SP) perpendicular to the BP and crossing the
optical rays of sources and detectors was first ali gned to pass
through the initial pair of source marks (Ml and M2). (b)
Each source or detector path was then simplified as a single
chief optical ray perpendicular to the straight line connecting
the source marks (Ml to M2). The sources and detectors
along the chief optical rays were then projected onto the
surface of the solid breast model. The SP was next rotated
around the rotation axis step-by-step with a 3-deg increment
per step for projecting sources and detectors at all scanning
steps.
FIG. 18 shows characterization of source ali grnnent errors
at different scanning steps of ncDCT. (a) The projected
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source close to M6 is used for demonstration. Line 1 and
Line 2 are perpendicular projections of M6-M2 and M6-M5
on the BP, respectively. The lengths of Line 1 and Line 2 are
defined as I,an and Irad, respectively. Plane 1 crosses MS and
M6 while Plane 2 crosses M6 and is perpendicular to Plane
1. Both Plane 1 and Plane 2 are perpendicular to the BP. (b)
a,an and arad are the distances between the aligned and
marked source points along tangential and radial directions,
respectively, which can be measured by the distances from
the aligned source point to the Plane 1 and Plane 2, respec
tively
FIG. 19 shows ncDCT modeling procedures and results of
solid breast meshes with the sources and detectors aligned
on the mannequin (upper panel) and human (bottom panel)
breasts. The images of mannequin (a) and human (d) breast
surfaces and corresponding reference planes were obtained
by the 3-D camera. The 3-D solid breast models were
generated by extruding the 2-D circular contours on BP
along the rotation axis to the breast surfaces. The breast
volume meshes [(b) and (e)] were then created from the 3-D
solid breast models. Finally, the sources and detectors were
aligned on the surfaces of solid volume meshes [(c) and (f)].
FIG. 20 shows ncDCT image reconstruction results from
computer simulations (upper panel) and the human breast
(bottom panel). (a) A breast mesh with an assigned sphere
anomaly (radius=5 mm) at the center of the ROI and 8 mm
beneath the surface of the mannequin breast. The red and
blue dots represent the sources without and with alignment
errors, respectively. The detectors are not shown for clarity.
(b) Reconstructed anomaly using the sources and detectors
without alignment errors. (c) Reconstructed anomaly using
the sources and detectors with assigned alignment errors. (d)
Ultrasound image of breast tumor (inside the dashed circle
area) in the human subject. (e) Reconstructed human breast
tumor using the solid breast mesh with the sources and
detectors aligned on the human breast. (f) Comparison of
tumor locations determined by ncDCT and ultrasound imag
ing on x-y plane: (1) the reconstructed tumor is projected on
the breast surface, (2) the central location of the tumor
determined by the ultrasound probe, and (3) source marks of
ncDCT scanning.
FIG. 21 shows a flowchart outlining the sequence and
commands used in the modified NIRFAST to generate a
forward model for ncDCT image reconstruction.
FIG. 22 shows a flowchart outlining the sequence and
commands used in the modified NIRFAST to solve diffuse
correlation tomography inverse problem for ncDCT image
reconstruction.
FIG. 23 shows recovery of anomaly blood flow contrasts
inside the slab-shaped and breast-shaped volume meshes for
ncDCT image reconstruction. A sphere anomaly with a
diameter of 10 mm and 10-fold flow contrast was placed at
7 mm beneath the surface of background tissue volumes. (a)
and (e) show the original assigned anomalies inside the
volume meshes with sources and detectors aligned on the
mesh surfaces; (b) and (f) show the reconstructed anomalies
with full-width at half-maximum (FWHM) thresholds; (c)
and (g) show 2-D cross-section views of original flow
contrast distributions through the anomaly centers; (d) and
(h) show the 2-D cross-section views of reconstructed flow
contrast distributions.
FIG. 24 shows evaluation of reconstruction accuracy of
ncDCT in the breast-shaped volume mesh. (a) and (b) show
the center location and deviation of the reconstructed
anomaly at different depths; (c) shows the percentage deviations of anomaly peak and average blood flow index (BFI)
contrasts at different depths; (d) and (e) show the linear
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relationships between the assigned and reconstructed peak
and average BFI contrasts at different depths.
FIG. 25 shows noise influence on imaging accuracy of
ncDCT. An anomaly was placed beneath the surface of the
breast-shaped mesh with varied central depths from 7 to 15
mm. (a) and (b) show the center location and deviation of the
anomaly at different depths, reconstructed with or without
noise. (c) and (d) show percentage deviations of anomaly
peak and average BFI contrasts at different depths, reconstructed with or without noise.
FIG. 26 shows comparison of anomaly reconstructions
without and with a priori structural information for ncDCT.
The top [(a)-(e)] and bottom [(f)-(j)] panels show the recon
structed flow contrast distributions of an anomaly (assigned
a 10-fold flow contrast) located at 7 and 15 mm central
depths, respectively. (a) and (f) show reconstructed results
without the a priori structural knowledge of the anomaly; (b)
and (g) show the reconstructed results with the a priori
structural knowledge; (c) and (h) show the reconstructed
results without the a priori structural knowledge and with
noise. (d) and (i) show the reconstructed results with the a
priori knowledge information and with noise. The flow
contrast profiles crossing the yellow lines are shown in (e)
and (j).
FIG. 27 shows clinical examples of two low-grade car
cinomas in situ using ncDCT. (a) Patient 1 (Pl) ultrasound
image taken from radio direction shows a 10.2x6.65 mm2
oval mass (inside the yellow dashed circle) with circum
scribed margins parallel to the skin. The mass center is
located at 19.2 mm beneath the skin surface. A core biopsy
revealed a ductal papilloma with low-grade ductal adenocarcinoma in situ. (d) Patient 2 (P2) ultrasound image shows
an 8.5x3.5 mm2 mass (inside the yellow dashed circle),
located at 13.3 mm beneath the skin surface. A core biopsy
revealed atypical ductal hyperplasia and low-grade carci
noma in situ. (b) and (e) show the reconstructed 3-D tumor
blood flow contrasts with FWHM thresholds for Pl and P2,
respectively. The backgrounds are presented with 30% trans
parency of the original color clarity. For the comparison of
ultrasound and ncDCT results, an ultrasound imaging plane
along the transducer line and across the overlapped two
specific sources (Sl and S2) is presented in the 3-D recon
structed image. (c) and (f) show the cross-section views of
tumor flow contrast images through the ultrasound imaging
planes, which can be directly compared to the 2-D ultra
sound tumor images [(a) and (d)], respectively.
FIG. 28 shows results measured by scDCT. (a) Original
intensity pattern for source S2 on the homogeneous phantom
using scDCT. (b) Desmeared intensity distribution of (a)
with a corresponding S-D separation axis. These images
depict contours of the intensity profiles with dots represent
ing 21 effective detectors for demonstrating the K distribu
tion with the S-D separations. Note that the dots are not to
scale and the smaller dots serve as an ellipsis for the
intermediate detectors.
FIG. 29 shows results measured by scDCT. (a) K for all
sources from detectors defined along the center row with and
without smear correction (SC) and numerically simulated K
at the S-D separations. (b) DB for center row detectors.
FIG. 30 shows results speckle contrast distributions from
Sl on homogeneous and heterogeneous phantoms, measured
by scDCT.
FIG. 31 shows reconstructed 3D flow contrasts measured
by scDCT. Three-dimensional overlaid cross sectional views
of the slab phantom (a) without heterogeneity and (b) with
heterogeneity. (c) Two-dimensional cross-sectional view (x
and y through side centers; z at 24.5) of the region with
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heterogeneity as extracted by half max contrast threshold
criteria. The true region with heterogeneity is depicted by
centered squares. (d) The extracted (half max contrast
threshold) region with heterogeneity obtained by computer
simulation. Images displayed with ParaView (Kitware,
N.Y.).
FIG. 32 shows phantom test results measured by the
nc_scDCT. (a) The point laser source (785 nm) and CCD
were focused onto a homogenous liquid phantom surface.
(b) Configuration of the point source and 37 detectors on the
CCD inside the FOY (c) Comparison of flow indices mea
sured at multiple detectors with or without polarizers cross
ing the source and detectors.
FIG. 33 shows in vivo test results in a human forearm
measured by the nc_scDCT. (a) The point laser source (785
nm) and CCD were focused onto the surface of forearm. (b)
Blood flow responses in forearm during 4-minute arterial
cuff occlusion measured by the nc_scDCT with source
detector (S-D) separations of 3, 6, 10, and 14 mm.
FIG. 34 shows results using nc_scDCT probe (a) on a
homogeneous slab phantom background with internally
placed tube-shaped anomaly of varied flow contrast (b).
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DETAILED DESCRIPTION
The present invention concerns improvements in the
fields of diffuse correlation spectroscopy (DCS) and diffuse
correlation tomography (DCT). The present invention
described herein provides for noncontact DCS (ncDCS),
noncontact DCT (ncDCT), speckled contrast DCT (scDCT)
and noncontact speckle contrast DCT (nc_scDCT) systems
and methods of using such for deep tissue flow measure
ments without probe-tissue contact, as well as novel
approaches to creating a reconstructed 3-D image of blood
flow distributions from data collected by these systems
through a modification to the finite-element-method (FEM)
based 3-D image reconstruction (originally designed for
DOT). The FEM-based image reconstruction allows for the
recovery of blood flow distributions in deep tissues with
arbitrary geometries. Both of these physical systems incorporate core DCS/DCT technology as set forth U.S. Pat. No.
8,082,015 (which is hereby incorporated by reference in its
entirety). Briefly DCS/DCT employs coherent near infrared
(NIR) light to probe deep tissues and single-photon-counting
avalanche photodiodes (APDs) to detect temporal speckle
fluctuations of the diffuse light on tissue boundaries. Long
coherence lasers and APD detectors are connected with
optical fibers placed on the tissue boundary for contact
DCS/DCT measurements. The measured temporal speckle
fluctuation depends on the motion of moving red blood cells
in the microvasculature (i.e. blood flow). By contrast, diffuse
speckled contrast imaging utilizes a charge-coupled-device
(CCD) to detect spatial speckle contrasts of the diffuse light
throughout the tissue.
Both ncDCT and nc_scDCT systems deliver and detect
NIR light through optical lenses to the surface of a tissue,
thereby removing the previously required need to be in
contact with the tissue. The ncDCT, which features ava
lanche photodiode (APD) detection, and the nc_scDCT
process, which features CCD detection, are distinguished by
the transition from temporal to spatial diffuse speckle inten
sity fluctuations. NIR light ranging from 650 to 900 nm is
generated by a coherent laser with the power of -100 mw.
The ncDCT approach uses a limited number of expensive
but highly sensitive APDs to detect temporal diffuse speckle
fluctuations for blood flow measurement, which limits the
system's spatial-temporal resolution and increases instru-
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mentation cost and dimension. With a linear array of APDs
in the ncDCT, coverage of the ROI is achieved by mechani
cally scanning the probe over the ROI for complete cover
age, which can take tens of minutes. By contrast, the
nc_scDCT approach uses a CCD to detect spatial diffuse
speckle contrasts for blood flow measurement. Hundreds of
detectors provided by a CCD unit omit the probe scanning
phase and significantly improve the spatial and temporal
resolution. Further, the CCD detection used in the
nc_scDCT allows for higher temporal (a few seconds) and
spatial resolution (1 to 2 mm) as well as lower cost and
smaller dimension of the instrument, compared to the APDs
used in the ncDCT. Further still, single-photon-counting
APDs used in ncDCT are more sensitive (but more expensive) than the CCD detection. Both systems are discussed
independently below.
With the systems described herein, the present invention
further provides, in part, for detecting and imaging blood
flow within a deep tissue. Through the type of detector
utilized (e.g., via APDs or CCD), tissue can be imaged from
the surface to approximately 1.5 cm depth within the tissue.
The tissue can be any tissue that is exposed such that NIR
light may be applied, such as a naturally exposed tissue, e.g.,
skin or during a surgical procedure or through the opening
of a generated surgical flap.
The present invention similarly provides methods for
assessing and monitoring a tissue. Those skilled in the art
will appreciate that the systems described herein can obtain
an image at any time that an image is desired. For example,
using the systems described herein, an image may be
obtained before, during and after surgical procedures to
determine the success of a procedure, to obtain a diagnosis,
or to review or follow a course of treatment. Those skilled
in the art will appreciate that the only limitation to obtaining
an image of a tissue is access to the tissue such that the
system can provide the requisite light.
The present invention further provides systems that can
measure or assess multiple parameters within a tissue. As
described herein, application of NIR light allows for the
detection and assessment of blood flow with a tissue. High
resolution imaging with multiple functional outputs has the
potential to guide the creation of more refined treatment
strategies that incorporate knowledge of heterogeneities to
yield higher intervention efficacy. NIR diffuse optical/fluo
rescence tomography (DOT/DFT) has gained great interest
as a fast, portable, and inexpensive technology for functional
blood oxygenation tomography (DOT) or fluorescence con
centration tomography (DFT). Through utilizing multiple
optical sources and fiber optical switches connected to NIR
lasers at different wavelengths (e.g., 785 nm and 830 nm),
other parameters such as tissue blood oxygenation or fluo
rescence (with optical filters) can also be detected. Thus,
through incorporating these other imaging methodologies
within the systems described herein, a hybrid DOT/DFT/
DCT system with nc or sc feature is achieved. Such other
detected parameters may then be independently imaged or
overlaid with one or more measured parameters (see, e.g. He
et al., J. Biomed. Optics. 18: 037001 (2013) and Shang et al.,
Optics Lett. 34: 3556-3558 (2009)).
Hardware Advancements
All systems discussed improve on limitations in applica
tion of the DCS/DCT technology (U.S. Pat. No. 8,082,015,
which is hereby incorporated by reference in its entirety).
Presented herein are several advancements in the apparatus
required for successfully obtaining a desired 3-D image of
blood flow distribution in deep tissue noninvasively. The
advancements feature the development of noncontact (nc)
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systems for APD-based DCT and the development ofCCD
the advancements in 3-D image reconstruction, as well as
based DCT (i.e., speckled contrast (sc) DCT). As discussed
that integrate with other operations to render such images.
herein, these advancements can be integrated to a DCS/DCT
In DOT theory, the detected photon fluence rate <I>(r,w) in
system in several ways.
highly scattering media such as biological tissues obeys the
The present invention therefore provides, in part, for 5 frequency-domain photon diffusion equation
systems and methods of using such that are capable of
V((D(r)/v)V<l>(r,w))-(µa(r)+iwlv)<l>(r,w)�-S(r,w)
(1)
producing a DCT image without contacting the tissue being
where
r
is
the
position
vector
and
v
is
the
light
speed
in
imaged. As shown in FIGS. 1 and 2, a DCS system that
the medium. (r) is the medium absorption coefficient, and
avoids contact with a tissue (the ncDCS apparatus depicted)
is a simple spectroscopic version of a DCT system (as 10 D(r)ssv/3µ)(r) is the medium photon diffusion coefficient
where µ)(r) is the medium reduced scattering coefficient. (r,
described herein) with limited numbers of sources and
w) is the isotropic source term modulated at angular fre
detectors.
quency w. The measurements use a point source continuous
FIGS. 3 and 4, depict two examples of a noncontact DCT
wave (CW) approach (w=O). In DCT theory, focus is on the
(ncDCT) apparatus that allows for noncontact 3-D imaging
of tissue blood flow distributions. These apparati feature a 15 unnormalized electric field autocorrelation function, G 1 (r,
-i:)=( E(r,t)E*(r,t+-i:)), obeying a formally similar CW diffu
noncontact imaging probe comprised of source fibers to
sion equation for DOT:
provide NIR light, such as through connection to connected
long-coherence lasers and a detector head that features an
V·((D(r)/v)VG1(r;t))-(µa(r)+
array of detector fibers. The probe can be positioned within
1
hµ;(r)ka2a ( L1.r2(i:)) )Gl (r,,)�-S(r)i'=j-,)
(2)
or around a region ofinterest to be imaged and near infrared 20
light is applied through the source fibers and to the tissue
where r is the position vector and v is the light speed in
the medium. µa(r) is the medium absorption coefficient, and
surface through a set of optical lenses. Following diffusion
D(r)ssv/3µ'/r) is the medium photon diffusion coefficient,
through the tissue, the detector fibers detect the diffused
µ's(r) is the medium reduced scattering coefficient, "t is
light, via a second set of optical lenses, which in turn allows
for measurement of the diffused light traveled through the 25 autocorrelation delay time, c is speed oflight in vacuum, and
A is wavelength. In practice, only the modulus is considered
tissue. As set forth in FIGS. 3 and 4, such systems allow for
with the right-hand side then resembling Eq. 1 in CW form
obtaining data without having the system contact the tissue
(i.e., -S(r)). Next is written µad(r,-i:)=1hµ)(r)k/a(&-2(-i:)),
or even the subject being imaged. As described herein, the
having the same unit as µa(r) and stemming from the
detector array can vary from a linear array to a 2-D array.
Further, the ncDCT system can be connected to motorized 30 common referral to 1hµ)(r)k/a(&-2(-i:))2 (i.e. V·((D(r)/v)
stages such that it can scan over the region of interest (ROI)
VG1 (r,1:))- (µa(r)+µad(r,1:))Gl(r,1:)=-S(r)e" =d,J) as the
"dynamic
absorption" ofcorrelation with delay time -i: due to
either rotationally (FIG. 3) or linearly (FIG. 4) to achieve a
dynamic processes. ko is the wave number of the incident
composite of multiple scans for 3-D image reconstruction.
light field. a is the unitless ratio of dynamic scatterers to
Such an approach, provides a somewhat lengthy sampling
time C-tens ofminutes) but reducing the cost (e.g., using less 35 total (dynamic and static) scatterers. (llr(-i:)) is the meansquare displacement in time -i: of the moving scattering
sources and detectors). By contrast, a ncDCT system that
particles (e.g., red blood cells); for the case of diffuse
features a 2D array of APDs does not require scanning,
motion, (llr(-i:))=6DB(r)"t where DB(r) (unit: cm2/s) is an
thereby reducing the sampling time C- a few seconds) but
effective diffusion coefficient ofthe moving scatterers. Thus,
increasing instrumentation cost and dimension by requiring
2
40 the dynamic absorption is redefined to µad(r,)=2µ)(r)k0 aDB
more sources and detectors.
(r)"t. The combined term aDB(r) is referred to as the blood
The present invention further provides, in part, for sysflow index in tissues and can be extracted by fitting the
terns and methods of using such that detect spatial speckle
analytical solution of Eq. 2.
intensity fluctuations in diffused NIR light. These spatial
speckled contrast advancements feature the introduction of
Proper algorithms for the forward/inverse solutions to Eq.
a charge-coupled-device (CCD) as the detector array within 45 2 can therefore be employed to reconstruct flow index
contrast. The FEM framework has been applied to model
the system, thereby providing a 2-D detector array capable
light transportation in comprehensive diffuse media to
of rapidly acquiring a 3D image. As seen in FIGS. 5 and 6,
resolve the geometry and heterogeneity limitations for DOT.
the scDCT and nc_scDCT systems provide for semi-nonExploiting the high mathematical similarity of the forward
contact or noncontact reflectance 3-D imaging of tissue
blood flow distributions. The scDCT system shown in FIG. 50 and inverse problems (e.g., boundary condition and maths is a semi-noncontact system (sources are still contacting ematical assumptions) between DOT (Eq. 1) with CW
source and DCT (Eq. 2), the application of FEM in DCT is
the tissue, primarily at the perimeter or boundary of the
achieved. This concept is introduced into the FEM-based
region of interest to be imaged with the CCD detector not in
light transport and image reconstruction modules from NIRcontact with the tissue), whereas the nc_scDCT system
shown in FIG. 6 is a fully noncontact system that utilizes 55 FAST as a shortcut for FEM implementation. NIRFAST is a
publically available image reconstruction package based on
different approaches for providing the sources that do not
the diffusive model and FEM method for DOT. DCT then
require contact ( e.g. multiple sources arranged around the
can be conceptualized as a formulation of DOT which with
CCD or through redirection by a Galva mirror).
CW computes G 1 (r,-i:) instead of<I>(r,w), by updating µa(r) to
Finite-Element-Method (FEM) Based Facilitation of
60 µa(r)+µad(r,-i:), and reconstructing µa(r)+µad(r,-i:) instead of
ncDCT Image Reconstruction
µa(r) only. The correlation function can be simulated using
The present invention also provides for new algorithms,
multiple delay times and combining all G 1 (-i:) along the time
software and computing systems incorporating such that
sequence "t. Reconstructed (r)+µad(r,-i:) then enables extractfacilitate the processing of data generated by the imaging
ing the flow index aDB(r) through the definition of µad(r,-i:).
systems discussed herein. Specifically, FEM-based algarithms for DOT are innovatively modified for the accom- 65 As a result, the realm of DCT becomes available for comprehensive imaging under arbitrary geometries and optical
plishment of DCT in tissues with arbitrary boundaries. The
properties.
present invention further incorporates systems that execute
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Image reconstruction from spatial speckled contrast sys
tems (e.g. scDCT/nc_scDCT) can similarly be achieved as
FEM-based ncDCT. For a certain CCD camera exposure
time, T, the spatial speckle contrast, K, is defined as the ratio
of the standard deviation, a, to mean, µ, intensities across
pixels in a chosen window (e.g. 7x7), i.e., K=a/µ. Using the
Siegert relationship, this spatial speckle contrast parameter
K can be related to the normalized temporal electric field
autocorrelation function gl by
(3) 10
where � relates detector and speckle size. We substitute in
the form of gl from the analytical solution to Eq. 1 for
semi-infinite geometry and find a nonlinear relationship
between speckle contrast and BFI, i.e., K2=f(aDB,T,µw µs',
A,�,S-D,ko) where S-D is source-detector separation. We
then minimize the squared difference between the experi
mentally measured speckle contrast and theoretical result,
(K2-f)2, with respect to extracting the blood flow index
(BFI). These calculated BFI's are then representative of the
boundary measurements for insertion into the modified
NIRFAST program as developed previously for FEM-based
ncDCT blood flow reconstructions.
The present invention further provides a smear correction
algorithm that can be employed to correct point-source
illumination contributions during image capture with the
frame transfer CCD and reflectance measurement setup.
Briefly, the speckle contrast obtained from a frame transfer
CCD camera may be deviated from the theoretical presence
by intensity disorder from the frame transfer process. More
specifically, visual stripes (smears) can be induced extend
ing from bright features in the image into the direction
opposite that of the charge transfer process. Along this
direction, the smear can be corrected using an algorithm
described by Eq. 4. The actual pixel intensity si gnal of the
x'h colunm and y'h row (x,y) can be restored by the measured
value i'(x,y) with
1

i(x,y)�i'(x,y)-ritr/nP TLn_/- i(x,n)

tr,

CT2 (/)- CT2 (/D )- �(/c )
µ 2 (/c)

20

25

30

35

(4)

where is frame transfer time, nP is number of pixel rows
when the frame has moved to the readout buffer, andri is the
efficiency with which photoelectrons are generated during
the charge-transfer process relative to the efficiency with
which photoelectrons are generated during the image cap
ture period. In the examples herein, the CCD frame transfer
time is -1 ms with set 7x7 windows at the same distance to
the source location for a symmetric intensity distribution,
leading tori value of 0.67.
Preprocessing of raw CCD images is required as follows.
Spatial speckle contrast contributions due to hardware noise
(i.e., shot noise and dark noise) are accounted for correcting
the speckle contrast computation, Kmeas=(a!µ), of win
dowed regions. Briefly, dark images are used to mitigate
speckle contrast influences from dark noise, Ic=I-In, where
I is the original intensity of a single pixel and In is the
intensity of dark current. The shot noise of le follows
Poisson statistics, (Ic)=v'(Ic), which are incorporated into
the correction calculation. The shot and dark corrected
speckle contrast is then given by

K=
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Noncontact DCS/DCT
The present invention provides in part for noncontact
measurement methodologies (ncDCS/ncDCT) for the char 65
acterization of tissue blood flow within deep tissue. FIGS. 1
and 2 show a possible apparatus arrangement for a ncDCS
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system that provides measurements of deep tissue blood
flow without contacting the tissue. NIR diffuse correlation
spectroscopy (DCS) has recently emerged as a highly advan
tageous blood flow monitoring modality, but requires con
tact-based interaction with the sample or tissue being exam
ined. Such contact measurements can promote
hemodynamic variations induced by compression or disturb
sensitive areas.
The present invention provides an apparatus and a method
of utilizing DCT without contact (ncDCT) for 3-D flow
imaging of deep tissue (FIGS. 3 and 4). The present inven
tion addresses the disadvantages associated with contact
based DCT systems, partially through a motorized stage for
automated and customizable ROI scanning capabilities. The
invention further provides a finite-element-method (FEM)
based facilitation of DCT image reconstruction of blood
flow distribution, which may be integrated into other sys
tems, such as an open software package for diffuse optical
tomography (DOT) termed NIRFAST. Validation of the
system is demonstrated herein through computer simula
tions and a phantom testing design allowing flow variations.
The present invention provides a noncontact probe that
utilizes at least two identical laser source paths and at least
one detector path for ncDCT (FIGS. 3 and 4). The source
fiber applies NIR light through the first set of optical lenses
to the tissue and the detector senses the applied light after it
has diffused through the tissue. In each source path, output
from a multimode fiber connected to a laser is projected onto
the tissue phantom surface through lenses. The numbers of
source and detector paths can be varied as needed. A detector
fiber head in the detector path contains single-mode fibers
equally arranged in a line covering a pre-determined range
though lenses at desired working distance. The photons
traveling through the sample are collected by a detector
array of APDs through the detector path. The array may be
linear or multi-linear. A multi-channel autocorrelator board
takes the APD outputs and simultaneously calculates the
temporal autocorrelation functions for each of S-D pairs.
Another facet provides the integration of a motorized stage
for automatic and precise ROI scanning through probe
translation.
FIGS. 3 and 4 show a possible apparatus arrangement for
a ncDCT system that provides 3-D imaging of deep tissue
blood flow distribution without contacting the tissue. Two
sets of optical lenses project source and detector fibers
respectively onto the tissue surface. The separation of source
and detector paths then allows for the arrangement of large
source-detector distances (up to 3 cm), thus providing for
probing deep tissues up to -1.5 cm depth. This noncontact
design allows for noninvasive hemodynamic assessment of
tissues, such as ulcerous tissues, which overcome the contact
limitations (e.g., the infection of wounds). Further, as
depicted in FIGS. 3 and 4, a linear array of APDs (e.g., 15
APDs) and two laser sources connected to a mobile lensfocusing system provide automatic and noncontact scanning
of flow in a region of interest (ROI). These boundary
measurements can then be combined with a FEM-based
facilitation of ncDCT image reconstruction for arbitrary
tissue geometry (as discussed herein), which can be then
pioneered and integrated into a system, such as the open
software package NIRFAST that was desi gned originally for
DOT34. Initial validation efforts for the innovative ncDCT
system have been made using computer simulations, tissue
phantoms, mammary tumors, and ulcerous tissues (see also
EXAMPLES section herein).
FIG. 13 provides examples of application of this ncDCT
in computer simulations and using a tissue-like phantom
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with anomaly flow contrast desi gn33. The cylindrical tube
shaped anomaly was clearly reconstructed in both simula
tion and phantom arrangements. Recovered and assi gned
flow contrast changes in anomaly were found to be highly
correlated. These results exhibit application of ncDCT for
3-D imaging of deep tissue blood flow heterogeneities.
The ncDCT imaging system has also successfully been
utilized on mammary tumors in human subjects (FIGS. 14 to
27)35 . ncDCT scanning procedures across the ROI (e.g., a
breast tumor), similar to those described in the phantom
experiments except that the breast tumor was scanned using
a rotational probe around the nipple. The breast tumors were
first determined by ultrasound imaging, then scanned by the
ncDCT probe. After DCT data acquisition, another scanning
was done with a commercial 3-D photogrammetric camera
(NextEngine, CA, USA) producing a boundary surface with
corresponding marks. This surface was extended into a solid
model using SolidWorks® and S-D locations were ali gned
on the model surface (see, e.g., EX. 3 herein). This solid
model was next converted to a solid mesh in ANSYS®. The
mesh and S-D spatial coordinates were then finally input
into the modified NIRFAST software enabling 3-D tomo
graphic reconstruction of blood flow contrast3 6-38.
To further investigate the application of the noncontact
systems, the ncDCS system has been examined on free
tissue transfer flaps where eight free flaps were elevated in
patients with head and neck cancer (see FIGS. 7-12, EX. 1
herein)39. Multiple measurements probing the same region
of the transferred tissue were continually performed before
and during surgery as well as on postoperative days. Post
operative blood flow values were normalized to the intra
operative baselines (assigning '1 ') for the calculation of
relative BFI change (rBF). FIG. 11 shows the results from all
eight cases including seven successes (Cases 1 to 7) and one
failure (Case 8). Interestingly, rBF changes/recoveries in the
unsuccessful flap during and post vessel anastomosis were
found to be smaller than all successful flaps, suggesting the
potential of ncDCT measurements for early prediction of
ischemic flaps.
2-D Source-Detector Array
The ncDCT system discussed above primarily concerns a
linear array of photodiodes to detect diffused NIR light.
Such a linear array can be systematically moved across a
region of interest to capture data set for 3D flow image.
Those skilled in the art will appreciate that using a 2-D
detector array that obtains data along two axes at once
removes or reduces the need to move the detector array.
While the mechanical scanning of a linear S-D fiber array in
ncDCT to cover a ROI provides a way to increase sampling
density and reduce cost, these approaches involve increases
in the time required for measurement and may be therefore
prone to the presence of motion artifacts. The present
invention therefore further provides for modification of the
ncDCT system that features a 2-D replacement of the linear
APD array (e.g. 2-D array of APDs, such as 15x15 APDs),
alleviating ROI scanning and cutting the acquisition time
from tens of minutes to a few seconds to minutes. Those
skilled in the art will appreciate that the number of APDs
(both in length and width of the detector array) present can
be adjusted to accommodate the region of interest.
CCD-Based Speckle Contrast Diffuse Correlation
Tomography (scDCT)
The present invention further provides for a 2-D detector
array comprised of a charge-coupled-device (CCD) that also
allows for data acquisition along 2 axes, thereby removing
or reducing the need to move the capturing detectors to
obtain data for the region of interest. An adjustable zoom
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lens is used to adapt a ROI with different areas. The
CCD-based spatial diffuse speckle contrast DCT (scDCT)
apparatus and method of use thereof combines the benefits
of CCD detection with the FEM-based DCT flow recon
struction discussed herein. Hundreds of S-D pairs provided
by the CCD allow one skilled in the art to omit a probe
scanning phase, si gnificantly improving the spatial and
temporal resolution, and reduce equipment complication,
dimension, and cost.
Application to reflectance tomographic imaging is pro
vided by the present invention through the development of
a robust technique that combines the benefits of CCD
detection and FEM-based DCT flow reconstruction41 -43 .
The imaging process can be simplified by converting the
speckle contrast to boundary flow indices and retaining the
leverage of FEM-based DCT reconstruction advancements.
This unique method, termed speckle contrast DCT (scDCT),
facilitates 3-D flow contrast imaging of complex turbid
media (see e.g. FIG. 5)4° . As this technique promotes
incorporation of both heterogeneous optical properties and
arbitrary tissue boundaries, scDCT utilizes highly representative sample characteristics in the recovery of accurate flow
data. This scDCT technique is applied on a reflectance-based
measurement which more adequately represents the situation encountered in larger subjects such as humans where
transmission is not practical in most cases (due to the limited
penetration depth of light), enhancing translatability. A
smear correction algorithm is also provided herein that
assists to resolve the influences on data uniquely incurred
when using frame-transfer CCDs with the point-source
illumination and reflectance setup. 6
Testing the scDCT for 3-D imaging of deep flow distri
bution in tissue phantoms with an anomaly is depicted in
FIG. 5 and FIGS. 28 to 31. A cube-shaped solid anomaly
(flow=O) with -7 mm side length was submerged -2 mm
beneath the surface of an Intralipid liquid solution (flow;,O).
A square metal holder positioned four source fibers in
contact with the liquid surface (FIG. Sa). An optical switch
distributed laser light (830 nm) into the four source fibers
(Sl to S4), sequentially. The configuration of anomaly
placement, sources, CCD detection area, and field of view
(FOY) is shown in FIG. 31b. Reconstructed 3-D and 2-D
cross-sectional views of the anomaly flow contrast are
shown in FIG. 3lc and FIG. 31d, respectively, which meet
our expectations.
Noncontact scDCT (nc_scDCT)
As with APDs, the systems utilizing CCD as a 2-D
detector array can be utilized in a manner that avoids contact
with the tissue being imaged. Such a system is referred to
herein as noncontact speckle contrast DCT (nc_scDCT). The
scDCT system itself, exemplified in FIG. 5, is a semi
noncontact system (i.e., sources remain in contact with the
tissue). A fully noncontact scDCT system (i.e., nc_scDCT)
can be achieved by using multiple source fibers that are
positioned around the CCD (such as affixed to the exterior
of the CCD lens as seen in FIG. 6a) or one source coupled
to a Galva mirror (see e.g. FIG. 6b). Both remove the need
of contact between the sources and the tissue. FIG. 6c shows
an example of a typical source-detector distribution diagram
for this system.
Sources and Detectors Ali gnment on 3-D Tissue Modeling
To render an image using the ncDCT system, first the
imaging probe is set at the desired working distance (as used
in the EXAMPLES herein, such a distance is -10 cm) from
the tissue area to be imaged. The autocorrelation function at
each sampling location is then taken while also automati-
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cally scanning the probe linearly (see, e.g. Lin et al., App.
Phys. Lett. 104: 121103 (2014)) or rotationally (see e.g.,
Huang et al. App. Optics 54: 8808-8816 (2015)). The width
of the region of interest with the systems exemplified herein
is typically around 4 cm wide. Next, boundaries of the
targeted area are obtained by a commercial 3-D camera. A
model of the tissue is then created with an arbitr ary surface
using a 3-D CAD software program, followed by the align
ment of sources and detectors to the surface of the 3-D
model. The boundary flow index is then fitted from the
obtained autocorrelation function for each S-D pair at each
sampling location. Collected data are then entered into
modified FEM-based software (e.g., NIRFAST) for 3-D
flow image reconstruction.
In instances of performing nc_scDCT, following setup of
the system and ensuring both source and detectors are
focused at the target surface, the surface intensity image
alternatively for each source location should be obtained.
Then, the boundaries of the target may be taken by a
commercial 3-D camera. Tissue is then modeled with an
arbitrary surface in 3-D CAD software and the sources and
detectors are aligned on the surface of the 3-D model. Then,
the intensity image is corrected for smeared intensity and the
speckle contrast K and correct related noises are calculated
as discussed above. The boundary flow index for each
detector from K is then fitted and flow index information of
the S-D set is combined with the forward and inverse
solutions from NIRFAST for 3-D flow image reconstruction.
Further References
The following are listed as background and to provide
further details to the features described herein. All are
hereby incorporated by reference in their entirety: 1.
Leachtenauer et al. Conference proceedings: Annual Inter
national Conference of the IEEE Engineering in Medicine
and Biology Society IEEE Engineering in Medicine and
Biology Society Annual Conference. 2006; 1:6380-3; 2. Liu
et al. J Rehabil Res Dev. 2006; 43:209-18; 3. Kanno et al.
Spinal Cord. 2009; 47:225-9; 4. Colwell et al. Plastic and
reconstructive surgery. 2011; 128:1170-8; 5. Spear S L,
Carter M E and Schwarz K. Prophylactic mastectomy:
indications, options, and reconstructive alternatives. Plastic
and reconstructive surgery. 2005; 115:891-909; 6. Spear et
al. Plastic and reconstructive surgery. 2014; 133:605e-614e;
7. Surgeons. ASoP. 2014 report of the 2013 statistics:
National Clearinghouse of Plastic Surgery Statistics. Avail
able
at:
www.plasticsurgery.org/Documents/news-re
sources/statistics/2013-statistics/plastic-surgery-statistics
full-report-2013.pdf . . . 2014; 8. Kanuri et al. Plastic and
reconstructive surgery. 2014; 133:448e-54e; 9. Haddad R I.
Multidisciplinary management of head and neck cancer.
New York: Demos Medical; 2011; 10. Holzle et al. Journal
of cranio-maxillo-facial surgery: official publication of the
European Association for Cranio-Maxillo-Facial Surgery.
2006; 34:25-33; 11. Lorenzetti et al. J Reconstr Microsurg.
2001; 17:163-167; 12. Prionas et al. Radiology. 2010; 256:
714-23; 13. Avril et al. Journal of clinical oncology: official
journal of the American Society of Clinical Oncology. 1996;
14:1848-57; 14. Durduran et al. Opt Lett. 2005; 30:2915-7;
15. Zhou et al. J Biomed Opt. 2007; 12:051903; 16. Yu et al.
J Biomed Opt. 2012; 17:010901; 17. Choe et al. PloS one.
2014; 9:e99683; 18. Choe et al. J Biomed Opt. 2009;
14:024020; 19. Tromberg et al. Medical physics. 2008;
35:2443-51; 20. Zhu et al. Radiology. 2010; 256:367-78. 10;
21. Fang et al. Radiology. 2011; 258:89-97; 22. Flexman et
al. J Biomed Opt. 2011; 16:076014; 23. Lin et al. Appl Phys

5

10

15

20

25

30

35

40

45

50

55

60

65

18

Lett. 2014; 104; 24. Boas et al. J Opt Soc Am A Opt Image
Sci Vis. 1997; 14:192-215; 25. Pryor et al. Otolaryngology
head and neck surgery: official journal of American Acad
emy of Otol aryngology-Head and Neck Surgery. 2006;
135:714-8; 26. Luu et al. Curr Opin Otolaryngo. 2009;
17:267-269; 27. Ichinose et al. J Reconstr Microsurg. 2004;
20:207-213; 28. Hanasono et al. J Reconstr Microsurg.
2009; 25:417-424; 29. Lorenzetti et al. Microsurg. 1999;
19:196-199; 30. Smits et al. J Appl Physiol. 1986; 61:66672; 31. Kienle et al. Phys Med Biol. 2001; 46:1231-44; 32.
Komorowska-Timek et al. Plastic and reconstructive sur
gery. 2010; 125:1065-73; 33. Lin et al. Applied physics
letters. 2014; 104:121103; 34. He et al. Commun Numer
Meth Engng. 2009; 25; 35. He et al. J Biomed Opt. 2015;
20:86003; 36. Choe R. Diffuse optical tomography and
spectroscopy of breast cancer and fetal brain. 2005; 37.
Wilson et al. Intl Cancer. 1991; 47:344-7; 38. Beaney et al.
Lancet. 1984; 1:131-4; 39. Huang et al. Journal of biomedi
cal optics. 2015; 20:75008; 40. Huang et al. Medical Physics
Letters. 2015; 42:4000; 41. Fercher et al. Opt Commun.
1981; 37:326-330; 42. Bi et al. Opt Lett. 2013; 38:1401-3;
43. Valdes et al. Biomed Opt Express. 2014; 5:2769-84.
EXAMPLES
Ex. 1: Noncontact Diffuse Optical Assessment of
Blood Flow Changes in Head and Neck Free
Tissue Transfer Flaps
The custom-made ncDCS system for the noncontact mea
surement of tissue blood flow is shown in FIG. 1. A
noncontact optical probe is held by a platform connected to
a linear motorized stage. A multiple axis stand holder
provides free movements to adjust the location and incident
angle of the probe. A DCS flowmetry is controlled by a
laptop for continuous monitoring of tissue blood flow as
soon as the noncontact probe is aligned over the target tissue.
The four-channel DCS device consists of a long-coherence
length (>5 m) NIR laser diode (785 nm, 100 mW, Crysta
Laser Inc, California), four single-photon-counting ava
lanche photodiodes (APDs, Perkin Elmer, Canada), and a
four-channel correlator (correlator.com, New Jersey). The
ncDCS system is integrated compactly and portably to
ensure convenient operation in both operating and patient
rooms.
FIG. 2(a) shows the details of the noncontact probe
structure. The source fiber (WF200/220/245, CeramOptec,
Massachusetts) connected to the long-coherence laser is
projected onto the tissue surface through achromatic lenses
[FIG. 2(b)]. The detector fiber bundle [FIG. 2(a)], including
California), are equally arranged in a 7-mm line to cover a
20-mm range through the magnification of lenses. The
source and detector fibers are aligned to focus on the tissue
surface.
Photons emitted from the laser are injected through the
source path into the tissue sample. Only a few photons
traveling through the sample can be eventually collected
through the detection path by the linear detector array of four
APDs. The four source-detector (S-D) distances are set as
10.0, 15.7, 22.8, and 30.0 mm [FIG. 10]. According to the
diffuse theory, the photon penetration depth is about half of
the S-D distance.28-30 Thus, for the probe structure described
above, corresponding light penetration depths range
approximately from 5 to 15 mm. The correlator takes the
four APD outputs and calculates the light intensity autocor-
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relation functions, which are used to extract tissue blood
flow information. The sampling rate of DCS measurement is
1 Hz.
Details about DCS theory and data processing have been
described in literature.21 •22•26•27•31•32 Briefly, light intensity
fluctuation with time detected by APD is associated with the
motion of red blood cells in tissue microvasculature and can
be quantified by the decay of the intensity autocorrelation
function calculated by the autocorrelator. From the normal
ized intensity autocorrelation function, the electric field
temporal autocorrelation function is determined, which sat
isfies the correlation diffusion equation in highly scattering
media.1 6 By fitting the electric field autocorrelation curve to
an analytical solution of correlation diffusion equation with
a semi-infinite medium geometry, a blood flow index (BFI)
is extracted.3 0 The relative change of blood flow (rBF) can
be calculated by normalizing the time-course BFI data to the
baseline value taken before physiological changes to be
studied.
Most previous DCS measurements were based on a
continuous manner, either with contact19•22•32-3 6 or noncon
tact2 6"27 probes, to quantify blood flow changes without
variation of the DCS device in long period intervals. In this
study, however, we intended to measure the same flap at
different days with the noncontact probe. In order to investigate ncDCS stability with this noncontinuous measurement
protocol, the ncDCS probe was first tested on a homogenous
liquid phantom placed in an aquarium. The tissue-like liquid
phantom comprised Intralipid (Fresenius Kabi, Sweden),
distilled water, and India ink (Black India, Massachusetts)
and has been used extensively for DCS calibrations.3 7
Intralipid particles provide control of scattering (µ)) and
Brownian motion (flow) while India ink controls absorption
(µa). We set µa=0.05 cm- 1 and µ)=7.0 cm- 1 . We measured
the same liquid phantom once a day over seven days. We
also tested the stability of ncDCS measurements on the
forearm of a healthy subject in a similar manner. For each
measurement in a day, flow data were taken for 2 min from
the same location of the phantom/forearm with the same
ncDCS probe. The flow values measured over seven days
were normalized to the first day, representing flow variations
over a week.
Blood Flow Measurement Protocol of Free Tissue Trans
fer
Seven patients with head and neck cancer undergoing free
tissue transfer participated in this study as part of their
oncologic extirpation and reconstruction procedure at the
University of Kentucky hospital. Written consents were
obtained from all patients as well as the healthy subject (as
a control for the forearm measurement) in accordance with
approval by the University of Kentucky's Institutional
Review Board. In total, eight free flaps were elevated on the
seven patients. Patient 7 underwent a flap that failed (case 8)
and another subsequent successful flap (case 7). Details for
patient demographic and reconstruction information are
listed in Table 1. All free flaps were raised in a usual
manner.3 8 After complete elevation of the flap with only the
main arterial pedicle and venae comitantes remaining
attached to its native blood supply, an optical measurement
using the ncDCS probe was performed [FIG. 7(a)]. After
this measurement, the arterial pedicle and venae comitantes
were ligated. The appropriate free flap was inset to recon
struct the corresponding head and neck defects and the
venous and arterial pedicles were anastomosed to recipient
vessels from the external carotid system and internal jugular
venous system. Each arterial pedicle was anastomosed in an
end-to-end configuration using 9-0 nylon sutures. Venous
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pedicles were attached in either an end-to-end or an end-to
side configuration using venous couplers.
TABLE 1
Patient demographic and reconstruction information
Patient Number
Pl (case 1)
10 P2 (case 2)
P3 (case 3)
P4 (case 4)
PS (case 5)
P6 (case 6)
P7 (case 7)
P7 (case 8)
15

Age

Gender Type of flap

63
65
54
46
64
74
74
74

M
M
M

F
F

M

F
F

RFFF

ALT
ALT

RFFF
RFFF
RFFF
RFFF
FFF

Successful flap?
y
y
y
y
y
y
y

N

Note:
RFFF, radial forearm free flap.
ALT, anterior lateral thigh free flap;
FFF, fibula free flap.
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Approximately 30 min after anastomosis of these vessels,
a second optical measurement was performed at the location
of the transferred tissue within the head and neck (oral
cavity, orbit, or neopharynx) [FIG. 7(b)]. In addition, mul
tiple optical measurements probing at the same location of
the transferred free tissue were performed on postoperative
days 2, 4, and 7 in a similar fashion to the intraoperative
measurement after anastomosis [FIG. 7(c)]. FIG. 7 illus
trates the protocol of blood flow measurements performed
specifically for the reconstruction of an oral cavity defect
(P7). In each setting, optical measurements were taken with
the ncDCS optical probe directed toward the cutaneous
surface of the reconstructed tissue and were kept at the same
working distance and spot throughout the protocol. During
intraoperative measurements, we took photos using a cam
era to record the locations of the ncDCS source. Note that
the focused light source point (785 nm) on the tissue surface
can be recorded by the camera. For postoperative measure
ments, we tried our best to align our probe to cover the same
region of the flap. DCS data collection time for each
measurement was approximately 2 min at a sampling rate of
1 Hz.
Data Analysis
The BFI data (2 min) obtained from the four S-D distances of ncDCS during the operation at the intraoperative
flap elevation step and on the three postoperative days (i.e.,
days 2, 4, and 7) were normalized to the averaged BFI
baseline values (assigning "1") taken at -30 min after flap
anastomosis, yielding rBF. The 2-min rBF data were then
averaged to generate mean rBF values at four S-D distances,
respectively. Finally, the mean standard deviation of the rBF
values at four S-D distances were calculated to represent the
rBF value and corresponding flow heterogeneity across the
measured bulk flap tissue. Statistical tests for averaged rBF
differences at different time points were performed using
one-way repeated measures AN OVA with main effects of the
time period. p value<0.05 was considered significant for
statistical results.
Results
FIG. 8 shows relatively smaller changes in flow over
seven days measured from the liquid phantom [FIGS. 8(a)8(d)] and healthy forearm [FIGS. 8(e)-8(h)]. Flow variations
over days measured at all S-D pairs were fairly constant,
indicating the stability of ncDCS for non-continuous mea
surements. By averaging rBF (or relative flow in the phan
tom) values over the four S-D separations, we found that the
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largest flow variations were only 1.09±0.23 from the phan
tom and 1.13±0.24 from the forearm (mean±standard devia
tion).
By contrast, remarkably larger rBF variations were
observed from all patients over the seven days. FIG. 9 shows
illustrative results measured from one typical successful
case (case 1) and the failure case (case 8). FIG. 10 shows the
average results over the seven successful cases; significant
differences were found among the flow responses obtained
from the four separations (one-way ANOVA test, p<0.001).
Although heterogeneous flow responses at different S-D
pairs existed due to the tissue heterogeneity at different
depths and regions of tissues, the trends of blood flow
alterations measured at different S-D separations were fairly
consistent in each case (FIG. 9) and over subjects (FIG. 10).
We then calculated bulk blood flow in the flap by aver
aging DCS data obtained from the four S-D detectors, which
represented the overall flap hemodynamics better than that
from a local tissue volume detected by a single S-D pair.
FIG. 11 shows these results from all eight free flap cases
including seven successes (cases 1 to 7) and one failure (case
8). Larger variations in rBF were observed in all patients at
all measurement time points. In the group data of successful
cases, an initial decrease of the blood flow was observed
intraoperatively (from the elevation of free flap to the end of
vessel anastomosis), followed by a graduate flow recovery
during the following postoperative days. By contrast, rBF
changes/recoveries in the unsuccessful flap during and post
vessel anastomosis were smaller than all successful flaps.
For better comparison, the averaged rBF values over the
seven successful flaps as compared to the unsuccessful flap
(case 8) are shown in FIG. 12. For the group data of seven
successful flaps, average intraoperative rBF at the time of
flap elevation was 1.71±0.12 (mean±standard error). Aver
age postoperative rBF on postoperative days 2, 4, and 7 were
1.89±0.15, 2.26±0.13, and 2.43±0.13 (mean±standard
error), respectively. The rBF variations over all measure
ment time points were significant (one-way ANOVA test,
p<0.001). By contrast, rBF values observed from the unsuc
cessful flaps were 0.82, 1.14, and 1.34, respectively, at the
time of flap elevation and on postoperative days 2 and 4,
which were apparently lower than the successful cases.
Discussion and Conclusions
This study focused on evaluating the microvascular cir
culation of free flaps both intraoperatively and postoperatively using a novel ncDCS technique. Due to previous
blood flow measurements using DCS or ncDCS performed
mostly in a continuous manner, 1 9• 22•26•2 7•32-36 a challenge of
this study was the quantitative stability of the non-continu
ous measurements over several days. To facilitate a quantitative comparison during perioperative monitoring period (7
days) in the protocol, rBF (or relative flow) in the liquid
phantom with a stable flow and in the healthy forearm were
monitored by ncDCS once a day over one week.
The results demonstrated fairly stable flow values during
the non-continuous measurements (see FIG. 8). The mean
flow variations over the four S-D pairs during the measure
ment period were less than 9% (phantom) and 13% (fore
arm), respectively. By contrast, the results shown in FIGS.
9-12 indicated significantly larger flow variations in the
reconstructed flaps over the perioperative measurement
period. The perioperative variations of blood flow in the
elevated flaps meet the expectation of physiological
responses to any surgical insult. There is almost always an
initial drop of blood flow after vessel anastomosis as fresh
flaps are ischemic.3 9 The postoperative continuous increase
in rBF results from the gradual recovery of tissue injuries
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associated with the decrease of vascular resistance in those
elevated flaps.7 Depending of the degree of ischemia and the
amount of time before recovery of blood flow, the flap will
either die or recover.3 9 Interestingly, blood flow in the
unsuccessful case did not show either the initial drop of
blood flow after vessel anastomosis or the postoperative
recovery. Although more cases need to be performed, the
observed perioperative differences in blood flow between
the unsuccessful and successful flaps (see FIGS. 11 and 12)
demonstrate the potential of ncDCS measurements to predict
early free flap failures.
Our results are comparable to data available in literature
obtained using other technologies such as laser Doppler 8 and
ultrasound Doppler.4-6 For example, intraoperative
decreases in blood flow after flap anastomosis6•8 and post
operative increases/recoveries in blood flow/velocity 4•5 • 8
were observed, which are similar to our results (see FIGS. 10
and 12). A previous case study also reported lower blood
flow after anastomosis in an unsuccessful flap.6 In addition,
preliminary results from a pilot study showed the potential
of blood flow measurements using laser Doppler to predict
flap failure before other clinical signs.8 However, in contrast
to ultrasound or laser Doppler technology that focuses on
evaluating blood flow/velocity in large vessels or superficial
tissues, the nature of ncDCS measurement is to quantify
blood flow changes in deep tissue microvasculature.20•26
Since appropriate blood flow in tissue microvasculature is
the key for the survival of flaps,49•41 ncDCS may become a
useful tool with more sensitive measurements than the
ultrasound/laser Doppler technology in monitoring tissue
flap vascularity. The ncDCS technology is feasible for
perioperative measurements of tissue blood flow in all flaps
included within this study, despite the anatomical challenges
that these flaps present intraoperatively and postoperatively.
These findings are encouraging as this technology may offer
surgeons the ability to assess tissue blood flow in real time
during the surgery, immediately after vessel anastomosis, as
well as in the early postoperative period when flap compro
mise is the highest. A prominent advantage of the ncDCS
system is the use of its noncontact probe, which allows
measurements to be taken under nonsterile conditions. It
also avoids potential distortion in blood flow signals result
ing from contact-probe compression on the target tissue.
Furthermore, the noncontact probe is able to assess blood
flow over the reconstructed tissue without interfering with
the sterility of the surgical fields and the surgical setup.
Several challenges have arisen in the early implementation
and use of this device. The complex anatomical configura
tions of head and neck reconstructions and patients' limita
tions have been successfully addressed. For example, flaps
used to reconstruct the oral cavity are difficult to assess fully.
Adaptations by measuring through the intact skin and sub
mental tissues up to the reconstruction tissue have shown
promise (cases 5 and 7). Practically, tissue blood flow can be
assessed approximately up to 15 mm below the skin surface
with this current model of the DCS system (i.e., half of the
maximum S-D distance of 30 mm).
However, tissue congestion and edema may affect light
penetration and blood flow measurement, which needs fur
ther evaluations using tissue-simulated phantoms.42 In this
study, tissue blood flow was measured by ncDCS intraop
eratively and postoperatively. During intraoperative mea
surements, the patient was anesthetized and thus there was
no motion artifact in blood flow measurements. During
postoperative measurements, the subject was asked to keep
still during the short period of measurements (-2 min). We
did not find obvious motion artifacts in postoperative mea-
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surements either. Moreover, we averaged the 2-min data to
reduce the variation during measurements. In addition, the
potential influence of probing tissue curvature on ncDCS
flow measurements has been previously investigated by our
group. 27 The results revealed that curvature resulted in slight
underestimation in BFI, but not in rBF. Blood flow quanti
fication in this study was performed by ncDCS in a longi
tudinal time frame with limited point measurements (i.e.,
four S-D pairs). We indeed observed the heterogeneity of
blood flow responses at different depths and regions due to
the tissue heterogeneity (see FIGS. 9 and 10). Ideally, 3-D
imaging of flap would provide complete information for
predicting the flap viability. However, our ncDCS system
has limited numbers of sources and detectors and thus
cannot generate a 3-D flow image. Recently, ncDCS has
been extended in our laboratory to the noncontact diffuse
correlation tomography (ncDCT)42 and speckle contrast
diffuse correlation tomography (scDCT).43 Both ncDCT and
scDCT have the potential to assess the spatial flow distri
butions in deep flaps with 3-D tomographic information.
In conclusion, we were able to use the ncDCS in multiple
and complex head and neck reconstructions with different
free tissue transfers. ncDCS is a promising tool that may
provide objective information regarding flap viability in
real-time intraoperatively and in the early postoperative
periods, thus allowing surgeons early identification of those
compromised and ischemic flaps with the hope of salvaging
them.
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Ex2: Three-Dimensional Flow Contrast Imaging of
Deep Tissue Using Noncontact Diffuse Correlation
Tomography
Blood flow distribution in tissues can provide vital information to healthcare professionals including clinicians and
research investigators. Alterations in blood flow may result,
for example, in regions of tissue presenting with ischemia
and hypoxia. These abnormalities are associated with and
help characterize many diseases including pressure ulcers,
stroke, and cancer. Furthermore, blood flow contrast imag
ing can assist in applications such as cancer diagnosis and
therapy monitoring.1 Near-infrared diffuse correlation spec
troscopy (DCS) has emerged as a highly advantageous blood
flow monitoring modality through inherent noninvasiveness,
safe application, portability, deep tissue probing (up to
several cm), and relative affordability.1-4 Most DCS systems
employ contact-based interaction with the sample. However,
in tissues, contact measurements can promote hemodynamic
variations induced by compression or disturb sensitive areas.
We have recently developed a noncontact DCS system that
uses a lens-focusing technique to circumvent these influ
ences.2 ·4
Despite advances in DCS applicability there have been
limited tomographical imaging realizations. A few studies
involving three-dimensional (3-D) diffuse correlation
tomography (DCT) have been performed with tissue-like
phantoms, computer simulations, and in vivo rat brain.5-7 An
early contact-based approach was applied to phantoms,5 but
is disadvantaged in vivo as described previously. Very few
noncontact-based DCT examinations have been conducted
as well. In these, lenses were positioned between a sample
and optical fiber grid connected to light and detection
elements.6 .7
These arrangements, however, were only tested on small
animals with limited source-detector (S-D) separations rang
ing from 2 to 10 mm. Flexibility is minimal and expense
increases with the scaling of the region of interest (ROI).
Another limitation of these studies is reliance on analyti
cal solutions assuming a simple semi-infinite geometry and
strict heterogeneities (e.g., spherical) of tissue which pre
cludes the transition to complex boundaries and imperfect
heterogeneities. Complications would also become apparent
in accommodating complex boundaries with numerous S-D
fibers. Furthermore, in testing these types of systems, the
imitation of flow contrast changes often relies on solid
phantoms (no flow) embedded in liquid phantoms (Intra
lipid; Brownian particle motion) or the converse case. This
method lacks elegance due to the restrictively static nature
of the components once prepared, specifically the solid
phantom material. The current study seeks to remedy many
of these concerns. First, we extended our noncontact DCS
system 2•4 to noncontact DCT (ncDCT) using a motorized
stage for automated and customizable ROI scanning capa
bilities. Next, a finite-element-method (FEM) based facili
tation of DCT image reconstruction was accomplished
through integration into an open software package for dif
fuse optical spectroscopy/tomography (DOS/DOT) termed

US 9,861,319 B2
25

NIRFAST. 8 Finally, validation efforts included computer
simulations and a phantom testing design allowing flow
variations.
Extending DCS into DCT attaches the burden of collect
ing many boundary measurements. As such, our noncontact
probe was upgraded to have two identical laser source paths
and one detector path (FIG. 4(a)) doubling our previous
number of available S-D pairs. In each source path, output
from a multimode fiber (WF200/220/245, CeramOptec,
MA, USA) connected to a laser was projected onto the tissue
phantom surface through lenses.2·4 The detector fiber head
(FIG. 4(b)) in the detector path contained 15 single-mode
fibers (SM800-5.6-125, Fibercore, CA, USA) equally
arranged in a 7 mm line covering a 20 mm range through
lenses at 100 mm working distance. The resulting S-D
separations were in the span of 10 to 30 mm, thus allowing
up to -15 mm penetration depth.1 Instrument operation
involves two 825 nm long coherence lasers (coherence
length>5 m, CrystaLaser, NV, USA) emitting photons to
tissue through individual source paths alternatively. The
photons traveling through the sample are collected by a
detector array of 15 avalanche photodiodes (APD, Perkin
Elmer, Canada) through the detector path. A multiple chan
nel autocorrelator (Correlator.com, NJ, USA) takes the APD
outputs and simultaneously calculates the correlation functions for the 15 S-D pairs per source.3 Another significant
improvement was the integration of a motorized stage for
automatic and precise ROI scanning (FIG. 4(c)) through
probe translation. Either rotational or linear motion staging
is available to maximally fit the subject geometry (e.g.,
breast shape or slab shape). This design feature enables large
ROI coverage and flexible S-D arrangements without greatly
increasing hardware requirements and costs (e.g., fibers,
APDs, and correlators). In this study, the ncDCT modality
was motivated by the linear stage (T-LSM200A, Zaber,
Canada).
Application of DCS theory, as well as correction for
smearing is performed using the algorithms described
herein. To test our theoretical DCT technique through com
puter simulations, we first evaluated forward solution accuracy in a homogeneous situation (i.e., no anomaly). A slab
mesh [dimension (mm): 90 (H)x90 (W)x35 (D)] was gen
erated with total node number 73 949 simulating liquid
phantom solution in a slab shaped container (e.g.,
aquarium). Optical properties were set throughout at
µ)=8.00 cm-1 and µa=0.045 cm-1 close to breast tissue
values.9 The slab flow indices (aDB) were set close to
Intralipid phantom values5 •10 at lxl0-8 cm2/s and corre
spond to the background tissue. As shown in FIG. 4(c), the
noncontact probe was scanned linearly (mimicked in simulation) across the ROI in 15 steps with an increment of 4
mm/step generating a scanning area of 40 mmx56 mm and
450 (15 stepsx15 APDsx2 sources) effective S-D pairs. The
forward solution (i.e., G i (i:)) was calculated by the modified
NIRFAST with s from Oto 8xl0-6 s. Minimal simulation
aberrations over the measured ROI (1% mean discrepancy
and 1.45% standard deviation) were observed between aDB
extracted using the established semi-infinite analytical solu
tion2 of Eq. (2) and the assigned aDB. With the forward
solution verified, the next simulation embodied recovery of
an anomalous presence and subsequent contrasts. A cylin
drical tube-shaped anomaly [dimension (mm): 13 (Dia.)x80
(L)] was inserted beneath the middle of the ROI with a depth
of 12.5 mm from the tube center to the ROI surface. The
anomaly optical properties (i.e., µa and µ)) were matched to
the background tissue. The attributed anomaly aDB was
varied with contrast ranging from 0, 4, 8, 12, 16, and 20

26

5

10

15

20

25

30

35

40

45

50

55

60

65

times of the background (1xl0-8 cm2/s). Reconstruction was
conducted on a second mesh with coarse finite element
division (node number: 11 025) and the same optical properties. The delay time i:=3.2xl0-6 s was used to calculate
µad(i:). Due to limited ROI dimensions along the tube, only
partial anomaly reconstruction was possible (FIG. 13(a)).
For percentage flow change comparison, the reconstructed
anomaly peak flow value was normalized to the averaged
step differences of aDB. Both the shape (FIG. 13(a)) and
relative anomaly flow contrast changes (FIG. 13(b)) were
well reconstructed (regression slope=l.00, R2=1.00, and
p<lo-5 ). We also used a half maximum threshold to segment
the anomaly and then calculated its mean flow value. An
excellent linear relationship was also observed between the
reconstructed and assigned percentage flow changes (data
are not shown; regression slope=l.00, R2=1.00, and p<
10-5 ).
To evaluate the errors in depth reconstruction (localiza
tion) of the anomaly and their dependence on the size of
anomaly, we performed supplementary simulations using
the existing tube and a smaller tube [6 (Dia.) mm 80 (L)
mm]. The anomaly central depth was varied up to 16.5 mm
beneath the surface.
The reconstructed central depths of the tube anomalies
and the relative changes of flow index contrasts were
accurate when the assigned anomaly was localized in the
sensitive region of light diffusion (i.e., anomaly central
depth 12.5 mm; data are not shown). These simulation
results demonstrated the robustness of the proposed FEMbased ncDCT technique.
We next validated the developed system in practical
object measurements by phantom experimentation. A back
ground of liquid phantom was placed in an aquarium (FIG.
4(c)) and a pump-connected cylindrical tube anomaly was
filled with liquid and small pieces of solid phantom (FIG.
4(d)). The tissue-like liquid phantom comprised Intralipid,
distilled water, and India ink and has been used extensively
for DCS calibrations.4 Intralipid particles (Fresenius Kabi,
Sweden) provide control of scattering (µ)) and Brownian
motion (DB; a""l) while India ink controls absorption (µa).
We set µ; and µa , respectively, at 8.10 cm-1 and 0.044
cm-1 while quantifying them with a FD tissue-oximeter
(Imagent, ISS, IL, USA).11 To create flow index contrasts
against the background, a clear plastic tube [dimension
(mm): 13.5 (Dia.) 80 (L)] with a very thin wall (0.35 mm)
was placed at 12.5 mm (tube center to ROI surface) into the
background liquid phantom (FIG. 4). The tube was mostly
filled with small pieces of solid phantom (µ)=10.00 cm-1
and µa=0.10 cm-1) to randomize pumped particle motions as
Brownian motion and generate a diffusive circumstance for
photons. Solid phantoms comprised titanium dioxide, silicon, and carbon black. A peristaltic pump (HV-77201-60,
Cole Parmer, Ill., USA) connected in series with a hydraulic
capacitor that damped fluid pulsations was employed to
create step increases in steady flow from Oto 20 ml/min at
4 ml/min increments within the tube. The high percentage of
solid components (no particle motion therein) made the flow
index in the tube close to Owhen no flow motivation was
induced by the pump. The noncontact probe was first
calibrated to the homogeneous liquid phantom region to
unify aDB measurement for each S-D separation. The scan
ning procedure was linear as assumed in simulations. Total
scanning time was 20 min with 60 s sampling time per step
at 0.5 Hz DCS sampling rate for each laser. For each S-D
pair, the interval average (60x0.5=30 points) represents the
corresponding boundary measurement for that step. We used
identical reconstruction parameters as the simulation includ-
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ing slab mesh and delay time t with the exception of a
median filter application. This latter addition assisted in
stabilizing inherent experimental noise not encountered in
the ideal simulation.8 The relationship between macro
pumped flow (unit: ml/min) and micro particle motion (aDB
unit: cm /s) is complicated, but was confirmed linear. For
this case, the assigned flow represents the macro flow (pump
speed) rather than DCS indices. In FIG. 13(d), relative
macro and micro flow changes were presented in the same
way used in simulation. A tube-shaped anomaly was clearly
recognizable after image reconstruction (FIG. 13(c)). The
reconstructed flow indices accurately captured the flow
changes in the tube when quantified with the peak value
(FIG. 13(d); linear regression slope=0.97, R2=1.00, and
p<lo-5) and with the mean of segmented anomaly (data are
not shown; linear regression slope=0.99, R2=0.96, and
p<lo-3 ). The liquid phantom system provided both a cir
cumstance of complex dynamic particles and changes of
particle motion and possesses the potential for easily updat
ing tissue properties in both the background and the
anomaly.
In the simulations and phantom tests, we note that no
optical property mismatch between anomaly and back
ground was induced, i.e., li.µ)=O and li.µa=O. Our previous
studies have revealed that the mismatch of µa and µ; resulted
in estimation errors of DCS flow index.10 To evaluate these
influences on ncDCT, we carried out supplementary com
puter simulations and phantom experiments; the optical
properties of background or anomaly were changed to create
µa and µ; contrasts. We found that inaccurate µ; assump
tions resulted in much greater flow index contrast errors than
inaccurate µa, which are consistent with our previous find
ings.10 Nevertheless, the relative changes of reconstructed
flow index contrasts over a large range of property contrast
variations (2- to 3-fold) were accurately reconstructed even
with the incorrect assumptions of optical properties (data are
not shown). The problem of modeling such heterogeneity
can be solved by combining DCT with other FD or time
domain DOT imaging instruments. To our advantage, the
FEM-based implementation software proposed is fully
capable of incorporating such arbitrary heterogeneities.
Previous DCT studies emphasized assigning a selective
delay time t to each S-D pair based on the analytical or
approximate solution of Eq. (2) which relies on simple
geometry and optical properties as mentioned above.6 By
contrast, we propose to use a uniform T. From the view of
µa\t), assigning uniform t unifies the µa\t) on the same
time scale such that t does not generate extra µad(-i:) contrast.
-i: (3.2xl0-6 s) was selected in this study based on a few
simulations and exhaustive sensitivity optimization has not
yet been completed. Specifically, we selected several small
t values (-i:sl.9xl0-5 s) from the entire range (generally from
1.0xl0-7 to 1.0xl0-3 s) to reconstruct flow contrasts in
computer simulations for comparisons. The variations in the
mean values and regression slopes of flow index contrasts
reconstructed with different s were found to be 5±10% and
<5%, respectively (data are not shown), indicating the
robustness of ncDCT method in this range. Note that large
t (e.g., >l.9xl0-5 s) may lead to unstable results in recon
structed flow indices. Based on the definition of dynamic
absorption µad(-i:) in Eq. (2), a large "t may result in an
effective absorption (µa +µ/(-i:)) greater than the normal
range of tissue absorption, thus influencing the stabilities of
forward and inverse solutions in NIRFAST. A good -i: selec
tion is complicated by considerations such as the occurrence
of any weight distinctions or redundancies between equa2
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tions generated by different -i:. This may be especially true
when the flow contrast of the imaging anomaly differs
greatly.
Furthermore, recruiting multiple s (assemble more equa
tions at different time scales for each S-D pair) may promote
robustness in solving an ill-posed inverse problem. These
questions provide for further exploration.
In conclusion, we reported a ncDCT system for 3-D flow
contrast imaging. A FEM framework was introduced to
simulate temporal electric field autocorrelation diffusive
transport and reconstruct spatially distributed flow contrasts.
The imaging capability of flow contrasts was validated
through both simulations and phantom experimentation. We
tested the ncDCT system on a simple semi-infinite geometry
herein, but by incorporating other imaging modalities (e.g.,
MRI and photogrammetric scanning) arbitrary geometry can
be obtained. The noncontact breakthrough design enables
potential imaging of deep blood flow contrast in real human
tissues (e.g., breast tumor, pressure ulcer) without distorting
hemodynamic properties.
References: 1 Yu, Curr. Med. Imaging Rev. 8(3), 194
(2012); 2 Li et al., Sci. Rep. 3, 1358 (2013); 3 Cheng et al.,
Neuroimage 62(3), 1445 (2012); 4 Lin et al., J. Biomed. Opt.
17(1), 010502 (2012); 5 Boas et al., J. Opt. Soc. Am. A
14(1), 192 (1997); 6 Culver et al., J. Cereb. Blood Flow
Metab. 23(8), 911 (2003); 7 Zhou et al., Opt Express 14,
1125 (2006); 8 Dehghani et al., Commun. Numer. Methods
Eng. 25(6), 711 (2009); 9 Durduran et al., Phys. Med. Biol.
47(16), 2847 (2002); 10 Irwin et al., Biomed. Opt. Express
2(7), 1969 (2011); 11 Fantini et al., J. Opt. Soc. Am. B
11(10), 2128 (1994); 12 Diop et al., Biomed. Opt. Express
2(7), 2068 (2011).
Ex. 3: Alignment of Sources and Detectors on
Breast Surface for Noncontact Diffuse Correlation
Tomography of Breast Tumors
The altered tissue hemodynamics and metabolism in
tumor pathogenesis have been well documented. It has been
noted that the autonomic growth and spread of malignant
tumors are partially dependent on increased angiogenesis
arising from the increased metabolic demand 1-3 . Previous
studies in breast cancer reported that hypermetabolism and
increased angiogenesis were linked to increased blood flow,
total hemoglobin concentration, and tissue metabolism4-10.
For example, positron emission tomography showed significant tumor-to-normal tissue blood flow contrasts in breasts
up to fivefold higher4. In carcinomas compared to benign
lesions, flow velocities in large arteries adjacent to tumors
acquired by Doppler ultrasound were significantly higher by
up to threefold9. Thus, the functional imaging of tumor
hemodynamics/metabolism is an exciting new strategy and
provides a more finely grained and individualized under
standing of cancer pathophysiology and treatment • .
Near-infrared (NIR) diffuse optical spectroscopy/tomography (DOS/DOT) is a noninvasive, portable, and relatively
inexpensive tool for functional imaging of deep tumor
oxygenation6-8• 13- 15. NIR diffuse correlation spectroscopy/
tomography (DCS/DCT) has also been developed more
recently, which is capable of imaging blood flow distribu
tions in deep tissues16-23. Most of these diffuse optical
techniques deliver and receive NIR light using optical fibers
placed on top of the tissue surface. These contact-based
approaches may be disadvantaged for in vivo measurements
due to the distortion of tissue hemodynamics resulted from
the compression of probe contact on soft tissues with
irregular boundaries. To overcome this limitation, our labo11 12
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ratory has recently developed a noncontact DCS/DCT
(ncDCS/ncDCT) system for three-dimensional (3D) imag
ing of human tissue blood flow distribution without probe
tissue contact24-26 . A finite element method (FEM)27•2 8
based framework was also established facilitating ncDCT
image reconstruction for tissues with arbitrary geometries26 .
This ncDCT system has been tested in tissue-like liquid
phantoms with a simple semi-infinite geometry26. During
the test, a motorized linear stage was employed to carry out
ncDCT probe scanning over the flat surface of liquid phantoms. However, when applying the ncDCT system for in
vivo investigations, the system must be modified to adapt to
complex tissue boundaries. The goal of this study was to
adapt the ncDCT system for the use of tumor detection in
human breasts. For this purpose, we designed a motorized
rotational stage to scan over the breast tissue and used a
commercial 3D camera (NextEngine, California, USA) to
obtain breast surface geometry. Several challenges exist
when inputting the geometrical information to the FEM
based image reconstruction of ncDCT. First, the breast
surface contour mesh generated by the 3D camera must be
extended to a solid volume mesh to include the tissue
volume imaged. Second, because the data from the 3D
camera and ncDCT were collected in different coordinate
systems, coregistration of the two coordinates is necessary.
Finally, the projected sources and detectors of ncDCT (sev
eral hundreds of pairs) on the breast surface must be
precisely aligned on the surface of solid mesh for the
accomplishment of image reconstruction.
Computer-aided design (CAD) is a powerful tool for 2D
and 3D solid modeling and coordinate transformation, and
has been increasingly applied in the biomedical field 29•30 .
The application programming interface (API) has been
recently introduced to CAD software (e.g., SolidWorks,
Dassault Systemes, Massachusetts, USA), which allows to
access and control CAD software easily. In this study, we
proposed a CAD-based approach to create the solid volume
mesh from the surface contour mesh (generated by a 3D
camera), to coregister the data obtained from the 3D camera
and ncDCT, and finally to align the sources and detectors of
ncDCT on the surface of the solid breast model.
We then evaluated the accuracy of source alignment on
the breast surface as well as the influence of alignment errors
on flow image reconstruction of breast tumor. This approach
lays the groundwork of ncDCT for in vivo imaging of spatial
blood flow distribution in breast tissues.
Methods and Materials
A. Motorized Rotational Probe for ncDCT Details about
ncDCT can be found elsewhere 26. FIG. 3 shows the
rotational probe design of ncDCT for the imaging of tissue
blood flow distribution in human breast. Two source fibers
(WF200/220/245, CeramOptec, Massachusetts, USA) con
nected to two long-coherence lasers (785 nm, CrystaLaser,
Nevada, USA) were projected alternatively onto the breast
surface through achromatic lenses [FIG. 3(c)]. The detector
fiber bundle [FIG. 3(b)] consisted of 15 single-mode fibers
(SMS00-5.6-125, Fibercore, California, USA), which were
equally arranged in a 7 mm line to cover a 20 mm range
through the magnification of lenses. A long-pass filter with
a cutoff wavelength of 750 nm (FEL0750, Thorlabs, New
Jersey, USA) was set in the detector path to reduce the
influence of ambient light.
The probe head was adjusted to focus the source and
detector fiber tips on the breast surface. Photons emitted
from the lasers were injected alternatively through the two
source paths into the tissue sample. Photons transported/
scattered through the sample were eventually collected

through the detection path by a linear detector array of 15
avalanche photodiodes (APDs, Perkin Elmer, Canada). The
distance between the two projected sources was 40 mm and
the resulting source-detector (S-D) separations were in the
span of 10 to 30 mm [FIG. 3(c)]. A multichannel autocor
relator (Correlator.com, New Jersey, USA) took the 15 APD
outputs and calculated the light intensity autocorrelation
functions to extract blood flow index. A linear stage
(5236A16, McMaster-Carr, Illinois, USA) and a custom
made rotational platform were used to manually align the
line-shape probe at the initial scanning position of a selected
region of interest (ROI) and approximately parallel to the
breast tissue surface
B. Scanning Procedure over Breast Tissue Surface. A
breast model of a plastic mannequin placed on a bed was
first used to explore the feasibility of the scanning protocol
over the breast. A laser pointer inside the rotation arm was
used to align the rotation axis approximately through the
nipple [FIG. 3(a)].
The optical probe was then adjusted to make the two
source chief rays approximately perpendicular to the surface
of the mannequin breast. The probe scanned 60 deg over a
ROI through 21 steps with a 3-deg increment per step. Total
scanning time was i<<25 min with 60 s sampling time per
step at 1 Hz sampling rate for each DCS laser source. The
projected source pairs at the 1st, 11th, and 21st steps, as well
as the rotation center, were visually marked on the breast
surface using a marker pen.
After ncDCT probe scanning, the breast surface with
marks was imaged by the 3D camera [FIG. 14(a)]. The
camera operated at a working distance of-17 in, and with a
field of view (FOY) of 10 inx13 in. [see the inset in FIG.
14(a)] and an acquisition time of -2 min. The mannequin
was then removed from the bed and a small foam pad
perpendicular to the rotation axis was attached to the DCS
scanner [FIG. 14(b)]. The 3D camera took another image to
include the small foam pad as a reference plane (RP), which
was used for the coregistration of two coordinate systems:
3D camera and ncDCT. Note that the 3D camera was kept
at the exact same position/location when taking the two
images [FIGS. 14(a) and 14(b)].
After the feasibility test in the mannequin breast model,
we used a similar but simplified protocol to scan over a ROI
on a realistic human breast. A 22-year-old female subject
who had a fibro-adenoma (benign tumor with no evidence of
malignancy) in the breast volunteered to participate in this
study after written consent in accordance with approval of
the Institutional Review Board at the University of Ken
tucky. The subject lay supine on the bed comfortably and her
body was fixed on the bed using soft form pads and pillows
to reduce potential body motion artifacts during measure
ments. The tumor location was determined by ultrasound
imaging, and the tumor mass margin along the longitudinal
and latitudinal directions was marked on the ultrasound
image. The ncDCT probe then scanned 60 deg over a ROI
throughout 16 scanning steps with a 4-deg increment per
step. This simplified protocol reduced the scanning time to
-17 min. Consequently, six marks of three source pairs were
made at the 1st, 8th, and 16th steps. Following ncDCT
scanning, in situ breast tissue optical properties (i.e., reduced
scattering coefficient µ; and absorption coefficient µa were
measured at three different locations by a commercial fre
quency-domain tissue oximeter (Imagent, ISS, Illinois,
USA).
The averaged µ; and µa over multiple sites were used as
initial inputs for flow image reconstruction. Finally, 3D
camera scanning procedures were performed identically to
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those used in the mannequin breast model as described
above. The total measurement time in the clinical room was
-25 min.
C. Solid Modeling of Breast Tissue Volume. For 3D flow
image reconstructions, a solid breast model/mesh including
the tissue volumes to be imaged is required. FIG. 15
illustrates the procedure to convert the mannequin (or
human) breast surface image acquired by the 3D camera to
a solid volume model. The 3D camera control software
(ScanStudio HD, NextEngine, California, USA) generated a
3D surface mesh with three pairs of source marks and a
rotation center mark [FIG. 15(a)]. The RP is also displayed
in the figure. A non-uniform rational basis spline (NURBS)
continuous surface was extracted by autofitting the nodes of
the surface mesh. We then created a bottom plane (BP)
parallel to the RP. The distance between the BP and the
rotation center point was set as 50 mm. Finally, a solid breast
model was generated by extruding a 2D circular contour on
the BP along the rotation axis to the breast surface [FIG.
15(b)]. This solid breast model including the marked ROI
was eventually used to generate a 3D tissue volume mesh for
flow image reconstruction. The volume of the solid breast
model was determined by the area of 2D circular contour,
the angle of the extruding, and the distance between the BP
and the rotation center point. These parameters should be
selected individually to ensure photons being diffused suf
ficiently inside a relatively large tissue volume31 . On the
other hand, the tissue volume should be minimized to reduce
the calculation burden for image reconstruction.
D. Coregistration of the Solid Breast Model and ncDCT
Coordinate Systems. The breast surface imaging and ncDCT
scanning were originally implemented in different coordi
nate systems (FIG. 16). For the coregistration of the two
systems, we defined the x-y plane of the ncDCT coordinate
system at the BP and z-axis along the rotation axis of the
ncDCT. The coordinate of the rotation center was thus at (0,
0, 50 mm). The initial scanning position of the ncDCT linear
array was aligned to the ncDCT system by adjusting the two
source rays through the source marks made at the first step.
This coregistration procedure allowed us to place the solid
breast model into the ncDCT coordinate.
E. Alignment of Sources and Detectors on the Surface of
the Solid Breast Model. For FEM-based ncDCT image
reconstructions, sources and detectors must be projected on
the breast tissue surface. We employed the CAD method
operated by API to define a scanning plane (SP) perpen
dicular to the BP and passing through the initial pair of
source marks [Ml and M2, FIG. 17(a)] and to mimic the
probe scanning procedure over the breast surface.
Each source or detector path in the SP was simplified as
a single chief optical ray [FIG. 17(b)] perpendicular to a
crossing straight line (Ml to M2). The two sources were
located at -L/2 and L/2 along the crossing line of length L
and the 15 detectors spanned in the range of -L/4 to L/4. We
then projected the sources and detectors along the chief
optical rays onto the surface of the solid breast model. The
projected points of intersection on the breast surface repre
sented the aligned sources and detectors at the initial scan
ning step. The SP with source and detector rays was repeat
edly rotated around the rotation axis for projecting sources
and detectors at all scanning steps onto the surface of the
solid breast model.
F. Evaluation of Source Alignment Errors. To characterize
the alignment errors at different scanning steps, we quanti
fied the distance from the aligned source points to the
corresponding source marks. The absolute alignment error
(a: mm) was measured by the distance between the ali gned
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and marked source points. The relative ali gnment errors
were evaluated along the radial (Yrad) and tangential (Y,an)
directions of the rotation by calculating the ratios of radial
and tangential distance deviations (a rad and a,an) to the
measured radial and tangential distances Orad and !,an),
respectively: Y,an=a,a)l,anxl00%; Yrad=arailradxl00%.
FIG. 18 demonstrates how to quantify the relative align
ment errors at the source mark M6. Briefly, two planes
(Plane 1 and Plane 2) were set up to be perpendicular to the
BP. Plane 1 crossed the mark pair of MS and M6 along the
radial direction while Plane 2 was crossing M6 and perpen
dicular to Plane 1 along the tangential direction. a tan and
arad were the distances from the ali gned source (nearby M6)
to the two planes, respectively. ! rad and !,an were the projected distances on the BP from M6 to MS and from M6 to
M2, respectively.
G. FEM-Based Flow Image Reconstruction of ncDCT.
Details about the FEM-based forward and inverse solutions
of ncDCT for blood flow imaging reconstruction can be
found in our recent publications26. Briefly, the facilitation of
DCT image reconstruction is accomplished through integration into an open software package for FEM-based DOT
termed NIRFAST27•28. Exploiting the high mathematical
similarity of the forward/inverse problems (e.g., boundary
condition and mathematical assumptions) between DOT and
DCT, we introduce a "dynamic absorption" of correlation
with delay time due to dynamic processes of moving scat
terers (primarily red blood cells). DCT can then be concep
tualized as a modified formulation of DOT, which computes
autocorrelation function instead of photon fluence rate. For
computer simulations, the autocorrelation function can be
generated using multiple delay times (e.g., 60 -i: was used in
this study) in the forward solution. For imaging reconstruc
tion, the blood flow distribution can be extracted using the
measured boundary data at multiple S-D pairs in the inverse
solution.
3. Results
A. Solid Models with Aligned Sources and Detectors
The mannequin breast model and the human breast were
used to demonstrate the CAD-based approach described
earlier. FIGS. 19(a)-19(c) illustrate the modeling procedures
and results obtained from the mannequin breast model. The
3D NURBS surface image [FIG. 19(a)] was transformed to
the solid volume mesh by ANSYS (ANSYS, Pennsylvania,
USA) with an average node distance of 2 mm [FIG. 19(b)] .
The sources and detectors were then aligned on the surface
of volume mesh [FIG. 19(c)]. Similarly, FIGS. 19(d)-19(t)
illustrate the modeling procedures and results obtained from
an in vivo human breast. The resulting volume meshes
[FIGS. 19(c) and 19(1)] with sources and detectors aligned
on their surfaces can be input into NIRFAST27•28 for ncDCT
image reconstructions26.
B. Source Alignment Errors
Table 2 summarizes the measured radial and tangential
distances Orad and !,an) at different source marks as well as
corresponding absolute and relative ali gnment errors of the
sources on the surfaces of mannequin and human breast. For
both cases, the absolute errors (a) increased with the
increase of scanning step, which is expected as the alignment was calibrated on the first pair of source marks (Ml
and M2). On average, the absolute error observed in the
human breast (0=2.64±1.65 mm) was larger than that in the
mannequin breast ( =0.79±0.50 mm). The mean relative
error in the tangential direction (Y,an =4.56±2.18%) was
larger than that in the radial direction (Yrad=2.43±1.17%),
indicating the major contribution of tangential errors to the
alignment errors. Similarly to the absolute errors, y tan
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increased with the increase of scanning step and its mean
value in the human breast (5.63±2.44%) was larger than that
in the mannequin breast (3.50±1.48%).

blood flow contrasts were 16.2-fold and 11.3-fold, respec
tively. The ultrasound image [FIG. 20(d)] shows a tumor
with the dimension of 19.0 mmx18.3 mm at the central

TABLE 2
Absolute and Relative Alignment Errors between tbe Projected Sources
and the Original Source Marks on the Manneguin and Hwnan Breasts

Case
Mannequin

Human

Marks
M3
M4
MS
M6
M3
M4
MS
M6

o(mm) a,an (mm) !,an (mm) Y,an (%) (Jrad(mm) lrad(mm) Yrad(%)
1.34
1.25
1.79
2.56
1.11
2.28
4.20
6.26

0.23
0.64
0.84
1.43
0.90
1.56
3.83
4.26

9.24
23.87
14.79
45.03
22.38
39.80
41.96
78.27

2.48
2.68
5.67
3.17
4.02
3.92
9.13
5.44

1.06
0.75
1.04
1.09
0.52
1.64
0.32
0.46

C. Impact of Source and Detector Alignment Errors on
Flow Image Reconstruction
In order to evaluate the impact of alignment errors on
imaging reconstruction of blood flow contrast, computer
simulations were conducted on the mannequin breast [FIG.
20(a)]. A sphere anomaly with a radius of 5 mm was
assigned to be 8 mm beneath the surface of the breast to
mimic a breast tumor. A solid mesh was created with 4 mm
node distance and was refined to 1 mm node around the
known anomaly region (-20 mm radius) to improve detec
tion resolution while not overwhelmingly increasing the
number of nodes. For simplicity, optical properties for both
anomaly and background were set throughout the tissue at
µa=0.06 cm-1 and µ)=6 cm-1. The flow indices for back
ground and anomaly were set as lxl0-8 cm2/s and 5xl0-8
cm2/s, respectively, resulting in a relative flow contrast
(rBF) of five-fold between the anomaly (tumor) and sur
rounding nodes (healthy tissues). We then assi gned align
ment errors of 10% in the rotation angles (i.e., 3.3 ° instead
of 3 °) for all sources and detectors at all scanning steps. For
example, the source alignment errors at MS and M6 were:
Ytan=l0.55%; Yrad=2.04% and Ytan=9.85%; Yrad=4.93%,
respectively. The levels of these errors are consistent with
our experimental results shown in Table 2. The impact of
ali gnment errors on the tumor location and blood flow
contrast was evaluated by comparing the reconstructed
results with and without alignment errors.
FIGS. 20(b) and 20(c) show the reconstructed anomaly
using the sources and detectors without and with alignment
errors, respectively. The reconstructed anomaly centers
deviated 1.30 mm (without ali gnment errors) and 2.07 mm
(with ali gnment errors) from the assigned original coordi
nate [FIG. 20(a)], respectively. The shift of the anomaly
central location (0.77 mm) was less than the node distance
(1 mm). When using a full width half maximum (FWHM)
threshold to segment the anomaly 32, the mean values of
reconstructed flow contrasts were 5.63-fold and 5.68-fold,
respectively. Thus, the deviation of average rBF contrasts
caused by ali gnment errors was less than 1%.
D. In Vivo Breast Tumor Reconstruction Using ncDCT
FIG. 20(e) shows the reconstructed 3D flow contrast
image of tumor inside the patient's breast using the FWHM
threshold to segment the tumor. The central depth and
dimension of the reconstructed tumor were 9.7 mm and 16.9
mmx15.5 mm, respectively. The measuredµa andµ; of the
breast tissue using the Imagent were 0.04 cm-1 and 7.8 cm-1,
respectively, which were used as inputs for flow image
reconstruction. The peak and averaged tumor-to-normal

35.33
32.46
39.20
34.61

3.00
2.12
3.20
3.35
1.32
4.18
0.92
1.33

depth of 13.0 mm beneath the breast surface. FIG. 20(1)
20 shows the reconstructed tumor projected on the surface of
the breast, which agrees with the tumor location on the x-y
plane determined by the ultrasound image.
4. Discussion and Conclusions
Most DCT measurements used optical fibers in contact
25 with tissues for photon emission/collection and required
tissues to conform to simple boundaries such as a slab. The
compression on the tissue may introduce distortions in tissue
hemodynamics33 . An obvious solution to this problem is to
30 place the sources and detectors away from the interface,
allowing for the noncontact imaging of arbitrary boundaries.
We have recently developed a noncontact DCT system and
have demonstrated its feasibility for 3D imaging of flow
contrasts in tissue phantoms with a simple flat surface 26. Our
35 ultimate goal is to translate this ncDCT system from bench
top to clinics for imaging of in vivo tissues with complex
geometries such as human breasts.
This reports a critical step toward the translation of the
ncDCT system for in vivo imaging of breast tumors. Cur40 rently, a variety of methods exist for obtaining irregular
tissue geometries. Previous studies for DOT have used
magnetic resonance imaging (MRI) 28•34•3 5 and computer
tomography (CT)3 6 to obtain solid volume meshes for imag
ing reconstruction. Hybrid systems combining DOT and
45 MRI have also been reported recently 37-40. However, the
high cost, large instrumentation, and poor mobility of MRI
or CT are major limiting factors for their frequent use in
clinic. Only a few studies used 3D cameras to generate tissue
surface geometries for DOT. For example, Dehghani et al.
so employed a 3D camera to scan over human breast surface
before placing the source and detector fibers on its surface41 .
Obvious deformation of breast tissues was observed after
placing the optical fibers for the contact DOT measurements.
Previous fluorescence tomography studies in small animals
55 (mouse or rat) used a 3D camera or CCD camera to acquire
animal surface geometry, where the animals were either
fixed in a small chamber42•43 or rotated over 360 deg44•45.
However, translation of these methods from small animals to
humans is not straightforward since many constraining
60 factors associated with human subjects must be considered,
such as safety, flexibility, and comfort.
Our study utilized a 3D camera to obtain the surface
geometry of the breast. The 3D camera can be placed at the
bedside close to the subject, which makes the operation
65 flexible in clinical rooms. The fully noncontact measure
ments by both 3D camera and ncDCT guarantee subject
safety and comfort. The CAD-based approach with API
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allows us to convert the 3D surface profile to the 3D solid
model, coregister the two coordinate systems (i.e., 3D
camera and ncDCT), and ali gn automatically the sources
and detectors of ncDCT on the surface of the solid breast
model.
Most of previous studies used a software such as Net
gen28, iso2mesh46, or Matlab43 to generate a volume mesh
from the surface mesh obtained by a 3D camera47 or
CCD 44. The source and detector locations on the surface of
volume mesh were determined by ray tracing on the indi
vidual surface mesh nodes. Therefore, the accuracy of S-D
ali gnment depended on the distance and distribution of
surface mesh nodes. By contrast, we aligned the sources and
detectors directly on the continuous surface (NURBS),
which was extracted by autofitting the nodes of the surface
mesh using CAD tools. Therefore, our ali gnment did not rely
on the surface nodes. Furthermore, the CAD-based align
ment method used in this study mimicked the same scanning
procedure of the ncDCT probe, thus providing an easy way
to assess the performances of scanning and ali gnment.
The accuracy of S-D ali gnment on the breast model is
critical as it affects the accuracy of flow image reconstruc
tion. Note that for simplicity the alignment accuracies in this
study were characterized based only on the representative
sources marked at the initial, middle, and final steps. We
observed in this study that maximal alignment errors over
scanning steps were less than 10%; i.e., 5.67% (mannequin)
and 9.13% (human) in the tangential direction, and 3.35%
(mannequin) and 4.18% (human) in the radial direction
(Table 2). On average, the relative errors in the tangential
direction were larger than those in the radial direction for
both mannequin and human breasts, and the tangential errors
increased with the increase of scanning step. These are
expected since any imprecision of mechanically rotational
scanning by the ncDCT probe should result in larger tangential errors along the rotation direction compared to the
radial errors. Furthermore, the tangential errors may be
accumulated with the increase of scanning step. By contrast,
the radial errors are generally not accumulative as the length
of the rigid scanning arm is fixed. In addition, perpendicularity between the rotation axis and the breast surface may
also affect the ali gnment accuracy. The mechanical scanning
errors can be reduced by using a high-precision motorized
stage and the non-perpendicularity may be corrected by
using an intelligent system to adjust the scanning axis based
on a dynamic scanning of breast surface geometry.
It is also not surprising that the tangential errors observed
in the human breast are larger than those found in the
mannequin breast because some influencing factors may not
be well controlled in human subjects, such as the irregular
shape of a real breast as well as a subject's breathing or
moving during the ncDCT measurement. However, the total
averaging time of 60 s for blood flow measurement at each
scanning step has greatly reduced the influence of a subject's
breathing. To reduce potential motion artifacts resulted from
body motion, we can re-mark source positions immediately
after the body motion occurs and use difference marks for
the alignment. Integration of all marked source positions for
the ali gnment can increase the ali gnment accuracy, which
will be the subject of our future work.
Computer simulations are commonly used to evaluate the
performance of an imaging system. In this study, the impact
of alignment errors on image reconstruction was determined
by quantifying the deviations of central location and flow
contrast of the assigned tumor inside the breast. The deviation of the reconstructed anomaly location (0.77 mm) result
ing from the alignment errors was found to be smaller than
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the mesh node distance (1 mm) and the deviation of recon
structed flow contrast due to the alignment errors was less
than 1%. Thus, the impacts of alignment errors on flow
image reconstruction are ignorable.
The results from the patient with tumor demonstrate the
feasibility of ncDCT in clinical use. The average tumor-to
normal blood flow contrast of 11.3-fold observed in this
study is comparable to previously reported flow contrasts of
2- to 10-fold in breast tumors detected by DCS 10•48, noticing
that tumor blood flow contrasts quantified by DCS may be
underestimated due to the partial volume effect. In addition,
the potential cross talk betweenµa,µ;, and blood flow may
also result in overestimation or underestimation of blood
flow contrasts49. W hen assuming homogeneousµa andµ)
over the entire breast, the realistic heterogeneousµa andµ;
over the tumor can generate errors in tumor blood flow
contrast. To overcome this limitation, a separate DOT instru
ment enabling 3D imaging ofµa andµ; distributions in the
breast is needed50051 .
The reconstructed tumor central depth of 9.7 mm is
slightly shorter than the ultrasound finding (13.0 mm). This
is likely due to the deep location of the tumor, which is
slightly beyond the sensitive depth of diffuse light detected
by our current ncDCT system. Based on photon diffuse
theory, the penetration depth of diffuse light is -1/2 of the S-D
separation [ 49]. The largest S-D separation of current
ncDCT is 30 mm, allowing for a penetration depth up to -15
mm. It is thus not surprising that the reconstruction errors
increased as the tumor (dimension based on ultrasound
image: 19.0 mmx18.3 mm) center was located at a depth of
13 mm. In addition, noises from clinical measurements may
also contribute to the reconstruction errors.
For the verification, we conducted computer simulations
with the same size/location of a spherical anomaly (diam
eter=18 mm) as the human tumor and similar level of
measurement noises. We observed that the reconstructed
anomaly was located at -10.9 mm beneath the breast surface
with a diameter of 15.1 mm (data are not shown), which
fairly agreed with our in vivo measurement results (i.e.,
tumor central depth=9.7 mm and dimension=16.9 mmx15.5
mm).
The focus of this study was to develop a CAD-based
approach to align the sources and detectors of ncDCT on the
surface of breast volume mesh for blood flow image recon
struction. We evaluated the accuracy of the source align
ments using computer simulations and on a plastic manne
quin and an in vivo human breast. Although we reported
only one in vivo human case in this paper as an example,
more simulations and in vivo imaging results from human
breasts have been recently published by our group52.
Theoretically, ultrasound imaging is not a part of ncDCT
setup. However, given that fact that our ncDCT is the first
optical imaging system providing 3D blood flow contrast
distributions in breast tumors, we do need to compare our
results with other standard imaging modalities (such as
ultrasound photography) for validation. Also, ultrasound
imaging of breast tumors helps us to determine the region of
interest for ncDCT scanning. In addition, a priori knowledge
of tumor location and volume can improve flow contrast
reconstruction [52], which will be the subject of our future
work.
In conclusion, we have developed a motorized rotational
probe for ncDCT imaging of breast tissues and a CAD-based
approach for the alignment of sources and detectors on the
surface of solid breast models. The generated breast volume
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37
mesh along with the boundary data collected from the
ali gned sources and detectors can be used for FEM-based
flow image reconstruction.
The results indicate that relative source alignment errors
on both mannequin and human breasts are less than 10%
throughout all scanning steps, which result in minor impact
on flow image reconstruction. The recovery of in vivo breast
tumor demonstrates the feasibility of ncDCT for clinical
applications. Furthermore, the ncDCT system has the poten
tial to be used for the imaging of deep blood flow distributions in a variety of soft or vulnerable tissues (e.g., breast
tumor, pressure ulcer, burned tissue).
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Ex. 4: Noncontact Diffuse Correlation Tomography
of Human Breast Tumor
The current clinical standard for breast screening is x-ray
mammography, with recent evidence confirming that mam-
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mograms offer substantial benefit for early cancer detection.
However, mammography is hampered by a significant false
positive rate, which is especially high for women with dense
breast tissue.
The dense breast population is a particularly important
subset of women because they experience higher incidence
and mortality rates from the disease.1 ·2 Other imaging diag
nostic tools for breast cancers include x-ray computed
tomography (CT), magnetic resonance imaging (MRI), posi
tron emission tomography (PET), and ultrasonography.3-5
Most of these imaging methods are prohibitively expensive
and generally only provide tumor morphological informa
tion with low specificity. Moreover, some of these tech
niques (e.g., CT and PET) expose patients to ionizing
radiation.6 .7
The autonomic growth and spread of malignant tumors
are dependent on increased angiogenesis arising from the
increased metabolic demand. 8 Since functional alternations
in tumors often appear earlier than detectable morphological
changes, functional imaging of tumor hemodynamics and
metabolism is a new strategy for early cancer diagnosis.9
Near-infrared (NIR) diffuse optical technologies provide a
noninvasive and relatively inexpensive tool for functional
imaging of tumor hemodynamics in deep microvasculature
up to several centimeters.10-1 3
The most commonly used NIR diffuse optical spectros
copy/tomography (DOS/DOT) can quantify total hemoglo
bin concentration (THC) and blood oxygen saturation
(St02) in tumors.14015 DOS/DOT has been used over several
decades to detect oxygenation alternations in breast
tumors.1 6-2° For example, THC was found up to 2-fold
higher in malignant lesions than nearby healthy tissues.15
More recently, a novel NIR diffuse correlation spectroscopy
(DCS) technique has also been developed for direct mea
surement of blood flow index (BFI) in deep tissues.21
A few pilot studies of breast tumors using DCS have
found increased blood flow inside the tumor in contrast to
surrounding normal tissues.10 Real-time monitoring of
breast tumor blood flow response to neoadjuvant chemo
therapy also demonstrated the potential of DCS for assessing
cancer therapies.22 ·23
Despite advances in DCS technologies, there have been
limited imaging applications of diffuse correlation tomog
raphy (DCT) for tumor detection. An early probe-tissue
contact-based DCT approach was applied to tissue phan
toms24 but was disadvantaged in vivo due in part to compression-induced hemodynamic alterations. A few noncon
tact-based DCT examinations have been conducted using
the camera lenses positioned between a sample and optical
fibers connected to source and detection elements.25 ·2 6
These arrangements, however, were only tested on the brain
of small animals with limited probing depth (<5 mm).
Another limitation of these imaging studies was their reli
ance on analytical solutions that assumed a simple semi
infinite flat tissue geometry.
Our group has recently developed a novel noncontact
DCT (ncDCT) system enabling three-dimensional (3-D)
imaging of deep tissue blood flow distribution without
contacting the tissue.21•27•28 Our ncDCT system employs
two sets of optical lenses to project source and detector
fibers, respectively, onto the tissue surface. The separation of
source and detector paths allows for the arrangement of large
source-detector distances, thus enabling probing deep tis
sues up to centimeters. Furthermore, a finite-elementmethod (FEM) based facilitation of ncDCT image recon
struction for arbitrary tissue geometry is pioneered and
integrated into an open software package (NIRFAST),
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designed originally for DOT.29 Initial validation efforts for
the innovative ncDCT system have been made using com
puter simulations and tumor-like phantoms on a simple
slab-shaped tissue boundary (i.e., semi-infinite geometry).21
This reports our first step to adapt the ncDCT system for
in vivo imaging of blood flow distribution in human breast
tumors. We used a commercial 3-D camera (NextEngine,
California) to obtain breast surface geometry and then
converted it to a solid volume mesh for ncDCT image
reconstruction.
Computer simulations were carried out to characterize the
performance of an ncDCT system for imaging an anomaly
(tumor) with varied flow contrasts and depths inside the
tissue volumes under different surface boundaries. The
mali gnant tumors inside human breasts (determined by
ultrasound imaging) were then scanned using the ncDCT
probe, and high tumor-to-normal flow contrasts were
observed in the reconstructed images. To the best of our
knowledge, we demonstrate, in this report, the first 3-D
blood flow contrast imaging of human breast tumors using
the noninvasive ncDCT.
Materials and Methods
Noncontact Diffuse Correlation Tomography System
Instrumentation
As reported previously,21 our ncDCT probe is a lens
focused apparatus, which has two identical source paths and
one detector path configured in a linear array. In each source
path, output from a multimode source fiber (WF200/220/
245, Ceram-Optec, Massachusetts) connected to a laser (825
nm) on the DCS instrument is projected onto the tissue
through lenses. Fifteen single-mode detector fibers (SM8005.6-125, Fibercore, California) are equally spanned in the
detector path connected to a detector array. The source
detector (S-D) separations vary from 10 to 30 mm, thus
enabling up to -15 mm penetration depth.21 Two long
coherence lasers at 825 nm (coherence length>5 m, Crys
taLaser, Nevada) emit light to tissue through individual
source paths, alternatively.
The photons traveling through the tissue sample are
collected by the detector array of 15 avalanche photodiodes
(APD, Perkin Elmer, Canada) through the detector path. A
multichannel autocorrelator (Correlator.com, New Jersey)
takes the APD outputs and calculates 15 correlation func
tions simultaneously. A motorized stage was integrated into
the optical system, which rotates the ncDCT probe around
the nipple for scanning a region of interest (ROI) on the
breast surface. The outcomes from this scanning are the
boundary data of intensity autocorrelation functions col
lected at hundreds ofS-D pairs on the ROI (see the example
in FIG. 25).
Diffuse correlation spectroscopy/diffuse correlation
tomography principle and noise model was utilized using the
algorithms described herein.
FIGS. 21 and 22 illustrate the main commands executed
for solving the forward and inverse problems, respectively,
in ncDCT using modified NIRFAST. A homogeneous back
ground tissue volume mesh with assigned initial optical
properties ofµa (r) and µ)(r) is first generated in the forward
solution (see FIG. 21). All S-D pairs corresponding to the
actual or simulated scanning of ncDCT probe are placed on
the surface of the background mesh. However, only those
with valid links between sources and detectors are config
ured as effective pairs for image reconstruction. An anomaly
region (mimicking a tumor) inside the background volume
mesh is then defined and assigned a BFI contrast relative to
the surrounding background. Based on the designed distri
butions ofBFis, µa'0'a1(r, -i:) is updated for each voxel inside
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the entire tissue volume within a certain range of -i:. The
autocorrelation functions G i (r, -i:) for multiple t from all
effective S-D pairs are then calculated by running the
forward model. The boundary BFI data at all effective S-D
pairs are then extracted by fitting G 1 (r, -i:) to the analytical
solution of Eq. (2) under semi-infinite homogeneous geom
etry. It is noted that even though the forward problem
simulates the light propagation in breast tumor models,
some commands (e.g., "Run forward model . . . ") are also
executed for experimental data reconstruction.
To evaluate noise influence on image reconstruction
through simulations, randomized noise varying at different t
is generated based on a noise model originally derived for
DCS.32•33 The noise level depends on the detected photon
count rate (i.e., light intensity) at each S-D pair, which is
estimated using the light intensity detected from in vivo
breast tissues (see Sec. 2.3). This noise is applied to the
simulated gir, -i:) curves. Multiple gir, -i:) curves with noise
are generated for each S-D pair and then averaged to
improve the si gnal-to-noise ratio (SNR). This simulation
mimics our in vivo measurements and data averaging pro
cess in human breasts. Finally, gir, -i:) curves are converted
to G i (r, -i:) curves to generate boundary BFI data.
Solving the inverse problem for image reconstruction is
conducted on a second mesh with a coarse finite element
division (pixel basis)29•34 (see FIG. 22). Initial values of
background BFI and optical properties [µa Cr) and µ)(r)]
along with the selected -i: (-i:=t1 was specifically noted herein)
are assigned to generate a homogeneous inverse mesh. The
simulated or measured boundary BFI data are converted to
g 1 (r, -i:) at the selected t using the semi-infinite analytical
solution ofEq. (2),27033 03 503 6 and further converted to G1 (r, -i:)
by multiplying with G i (r, 0). The boundary G i (r, -i:) is then
input into the inverse model to reconstruct the µa'0'a1(r, -i:)
distribution inside the entire tissue volume. The BFI distri
butions are finally extracted through the definition of µad(r,
-i:).
Computer Simulation Protocols
We conducted several computer simulations to characterize the performance of the ncDCT system. The first simu
lation tested the abilities of ncDCT in recovery of an
anomaly (tumor) beneath the surfaces ofa slab and a female
plastic mannequin breast (see herein). The second simula
tion evaluated the reconstruction accuracies of the anomaly
with varied depths and flow contrasts in the same plastic
mannequin breast. The influence of noise on ncDCT image
reconstruction was also assessed and compared with the
results without noise. The last simulation applied a priori
structural knowledge of the anomaly in the inverse mesh to
improve the accuracy of flow image reconstruction.
Reconstructions of a tumor in slab-shaped and breast
shaped tissues
To evaluate the reconstruction of an anomaly inside a
background tissue volume with a simple semi-infinite geometry, a slab volume [dimension (mm): lOO(H)xlOO(W)x40
(D)] was first generated in SolidWorksR (Dassault Sys
temes, Massachusetts) and then segmented into finite
elements using ANSYSR (ANSYS, Pennsylvania). A total
of 15,996 nodes were created with node distances of 3 and
6 mm in the ROI and the surrounding region, respectively
[FIG. 23(a)]. Different mesh resolutions were employed to
reduce the total node number while maintaining appropriate
spatial resolution in the ROI. The segmented mesh nodes
and elements information were then input into MATLABR
(Math Works, Massachusetts) to generate all mesh files
needed for the simulations with modified NIRFAST. The
slab volume mesh represented a healthy background tissue
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volume. A spherical anomaly with a diameter of 10 mm
mimicking a tumor was then placed at the ROI center, and
the anomaly centroid location was 7 mm beneath the surface
of background tissue volume [FIG. 23(a)]. Optical proper
ties for both tumor and background tissues were set homo
geneous throughout the entire slab as µ)=6.00 cm- 1 and
µa=0.06 cm- 1 .
The blood flow indices for the background and anomaly
were set as lxl0-8 cm2/s and lOxl0-8 cm2/s, respectively,
resulting in a 10-fold flow contrast between the tumor and
surrounding normal tissues [FIG. 23(c)]. The ncDCT probe
with a linear S-D array scanning rotationally over the ROI
was simulated for 21 steps with 3 deg/step to collect the
boundary data [FIG. 23(a)], where coordinates were calcu
lated with MATLAB. There were a total of 42 sources and
315 detectors distributed on the ROI. Thus, 630 (315x2) S-D
pairs were effectively available and used for image recon
struction. The autocorrelation functions G1 (r, -i:) from the
effective S-D pairs were calculated by the modified NIR
FAST software with t ranging from O to 3.2xl0-5 s (50
consecutive t). Reconstruction was conducted on the same
mesh with a pixel basis of 20x20x25 and a -i:1 =8.7xlo-6 s.
The t selection has been discussed in our previous publica
tion.21 The presenting anomaly was extracted with the
full-width at half-maximum (FWHM) criterion37 on the
reconstructed DCT image. The averaged BFI and the center
location of the reconstructed anomaly were computed by
averaging the BFis and node coordinates within the
anomaly.
In order to assess the ability of ncDCT for imaging a
tumor inside breast, we conducted a computer simulation on
a female plastic mannequin breast. The surface geometry of
the mannequin breast with source marks of ncDCT was
scanned by a commercial 3-D camera (NextEngine, Cali
fornia), which was further converted to a solid breast tissue
volume using Solid Works. To align the sources and detec
tors of ncDCT on the breast model surface for image
reconstruction, a scanning plane perpendicular to the breast
surface and crossing the optical rays of 2 sources and 15
detectors was created in SolidWorks.
The scanning plane was first aligned passing through the
first pair of source marks and then rotated step-by-step
around the rotation axis with an angle increment of 3 deg,
matching our experimental procedure [FIG. 23(a)]. At each
step, the sources and detectors along the optical rays were
projected onto the surface of the solid breast model.
Similar to the slab meshing, the solid breast volume was
segmented into finite elements with node distances of 3 and
6 mm in the ROI and surrounding region. A solid volume
mesh [largest dimension (mm): 100(H)x78(W)x(70(D)]
with total nodes of 14,717 was generated for simulations. A
spherical tumor with a diameter of 10 mm and a node
distance of 3 mm was then placed at the ROI center, and the
tumor centroid location was 7 mm beneath the breast surface
[FIG. 23(e)]. For comparisons, we assigned the same optical
properties and BFI contrast as those used in slab-tissue
simulation. The boundary data were also collected in the
same manner over the ROI on the breast surface. Identical
breast-shaped mesh with a pixel basis of 20x20x30 and
-i: 1 =8.7x10-6 s were used for image reconstruction.
Quantification of Tumor Location and Flow Contrast in
the Breast-Shaped Tissue
This simulation used the same tumor model in the breastshaped mesh with the same configuration and optical prop
erties [see FIG. 23(e)]. The tumor was placed beneath the
surface of the breast-shaped mesh with varied central depths
from 7 to 15 mm at 1 mm increment/step. It is noted that
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breast tumors with their centroid locations within the sen
sitive region of diffuse light (i.e., the detected penetration
depth ofNIR light is -1/2 of the S-D separation)3 5•38·39 were
our most interested study population, since more reliable
reconstructions can be generated. At each depth, the tumor
to-normal flow contrast was increased from 0- to 20-fold at
5-fold increment/step. The reconstructed tumor depth was
characterized as the shortest distance from the reconstructed
anomaly center to the breast mesh surface.
The measurement accuracy of the ncDCT system was
assessed by quantifying the discrepancies between the
reconstructed and assigned values in tumor central location
and flow contrast.
To evaluate the noise influence on image reconstruction,
we added noise on the subsets of boundary data collected
from the tumor with 10-fold flow contrast throughout all
varied depths. Forty gir, -i:) curves with noises were gen
erated and averaged at each effective S-D pair for DCT
image reconstruction.
Reconstruction with a Priori Knowledge of Tumor Loca
tion and Volume
To improve the reconstruction accuracy of anomaly blood
flow contrast, the soft-constraint method37•40-42 inNIRFAST
package was tested in this simulation. A priori structural
information of tumor (i.e., central location and tumor vol
ume) was included in the inverse mesh by labeling the nodes
in the inverse mesh according to the regions of tumor or
surrounding tissues. A regularization matrix L was applied to
the penalty term in the minimization function for the DCT
inverse problem, which was equivalent to applying a Lapla
cian-type filter to minimize variation within each region.
Simulations were done with the spherical anomaly (10fold flow contrast and diameter=lO mm) placed at either 7
or 15 mm central depth beneath the breast surface and with
or without noise.
In-Vivo Blood Flow Imaging of Human Breast Tumor
To explore the feasibility of an ncDCT imaging system in
clinical applications, two female patients with low-grade
carcinoma were recruited from University of Kentucky
Comprehensive Breast Care Center, with signed informed
consent approved by the University of Kentucky Institution
Review Board. The patient lay in a supine position and the
major tumor lesion inside the breast was determined by
radiologists using ultrasound imaging prior to the optical
measurement. The tumor mass margins along the radio
direction were marked on the ultrasound images.
The ncDCT probe was driven by a step motor to scan
rotationally around the breast nipple over the region of
breast tumor. The scanning procedures were similar to those
described herein. Briefly, 15 and 21 scanning steps were
taken to cover the tumor bearing regions in the two breasts,
respectively.
Forty gir, -i:) curves were collected from each S-D pair for
each patient, and two source pairs at the beginning and
ending steps of scanning were visually marked on the breast
surface as the references for the alignment of sources and
detectors on the surface mesh. The surface geometry of the
breast with the source marks was then recorded by the 3-D
camera for image reconstruction. Following the ncDCT
measurement, a commercial frequency-domain tissue oxi
meter (Imagent, ISS, Illinois)43 was used to measure µ; and
µa of the breast tissue at three different locations. The
averaged µ; and µa over the multiple sites were used as
initial inputs for flow image reconstruction.
The solid breast mesh of the patient was created in the
same way as that of the plastic mannequin breast. Boundary
BFis on the breast mesh surface were then extracted by
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fitting the measured gir, i:) curves from effective S-D pairs.
These boundary BFI data were then calibrated to the BFis
collected at the first scanning step, where the tissue under
neath the probe was outside the tumor region and thus
assumed to be homogeneous and healthy. The calibrated
boundary data were finally used for DCT image reconstruc
tion.
Results
Noncontact Diffuse Correlation Tomography Recovered
an Anomaly Inside Both Slab-Shaped and Breast-Shaped
Tissue Volumes with Similar Accuracies in Simulations
FIG. 23 illustrates 3-D [FIGS. 23(a), 23(b), 23(e), and
23(1)] and two dimensional (2-D) cross-section [FIGS.
23(c), 23(d), 23(g), and 23(h)] views of blood flow distri
butions in the slab-shaped (top panel) and breast-shaped
(bottom panel) tissue volumes, respectively. FIGS. 23(a),
23(e), 23(c), and 23(g) show the originally assigned/simu
lated anomaly inside tissue volumes and FIGS. 23(b), 23(1),
23(d), and 23(h) show the reconstructed results for com
parisons.
To clearly visualize the anomaly inside the tissue volume,
3-D background meshes were presented with 30% transpar
ency of their original colors. The reconstructed anomalies
were presented with FWHM thresholds in 3-D images
[FIGS. 23(b) and 23(1)] and without thresholds in 2-D
cross-section views [FIGS. 23(d) and 23(h)]. Table 3 sum
marizes the discrepancies between the assi gned and recon
structed anomalies inside the slab-shaped and breast-shaped
tissue volumes. These results indicate that the ncDCT sys
tem can recover the anomaly inside both slab-shaped and
breast-shaped tissue volumes with similar accuracies.
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TABLE 3
Computer simulation results in recovering an anomaly1 inside slab
shaped and breast-shaped volume meshes

Slab-shaped
Breadshaped

Anomaly
central
depth (mm)/
% error

Anomaly
diameter
(mm)/
% error

6.4/8.6%
6.65/7%

7.2/28%
7.5/25%

Peak flow
contrast/
% error

Average
flow
contrast/
% error

12.8-fold/28% 9.3-fold/7%
12.2-fold/23% 8.1-fold/19%

aA spherical anomaly with a diameter of 10 mm and 10-fold flow contrast was placed at
7 mm beneath the surface of background issue volumes.

Higher Reconstruction Accuracy Achieved in Simulations
when the Anomaly was within the Sensitive Region of
Diffuse Light
The reconstruction results with varied anomaly locations
and flow contrasts are presented in FIG. 24. The discrepan
cies [FIG. 24(b)] between the reconstructed and assigned
central locations ofthe anomaly were smaller than the mesh
node distance (3 mm) at all depths. The reconstructed
anomaly locations were more accurate in the sensitive
region of diffuse light (errors 0.5 mm at central depths 10
mm) compared to those in deeper depths.
Reconstruction errors in peak and average BFI contrast of
the anomaly at varied center location and assigned flow
contrasts are displayed in FIG. 24(c). The largest reconstruc
tion errors in peak and average flow contrasts ranged from
31.4% to -77.0% and -23.6% to -82.9% respectively,
through all varied depths and flow contrasts. Similarly, the
reconstructed peak and average BFI contrasts were more
accurate in the sensitive region of diffuse light (peak and
average BFI underestimations 27.8% and 45.3%, respectively, at central depths 10 mm) compared to those in larger
depths.
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FIGS. 24(d) and 24(e) demonstrate the linear relation
ships between the assigned and reconstructed peak and
average BFI contrasts. The relative anomaly flow contrast
changes were well reconstructed from the chosen central
depths of 7 mm (peak BFI: linear regression slope= l.03,
R2=0.99, and p<0.001; average BFI: linear regression
slope= l.02, R2=0.99, and p<0.001), 10 mm (peak BFI:
linear regression slope= l.01, R2=0.97, and p<0.01; average
BFI: linear regression slope= l.00, R2=0.97, and p<0.01), 13
mm (peak BFI: linear regression slope= l.07, R2=0.98, and
p<0.01; average BFI: linear regression slope= l.07, R2=0.98,
and p<0.01), and 15 mm (peak BFI: linear regression
slope= l.08, R2=0.98, and p<0.01; average BFI: linear
regression slope= l.08, R2=0.98, and p<0.01). The relationships between the assigned and reconstructed relative
anomaly flow contrast changes from other tested depths
were similar (results not shown here).
In total, these results indicate that relatively higher accu
racies were achieved when the entire anomaly was within
the sensitive depth of diffuse light. Also, even though the
recovery ofanomaly BFI contrasts was not as accurate as its
location, the reconstructed anomaly BFI contrast changes
were fairly accurate.
Noise Reduced Anomaly Recovery Accuracy in Simula
tions
FIG. 25 shows the ncDCT image reconstruction results
with simulated noise added to the forward problem. For
comparisons, images reconstructed from clean data (no
noise) and noisy data are plotted together. When the
anomaly volume was within the sensitive region of diffuse
light (anomaly central depth 10 mm), the largest discrepancy
between the reconstructed and assigned central locations of
the anomaly was 1.2 mm [FIG. 25(b)], 0.8 mm greater than
that (0.4 mm) without noise. Similarly, the largest reconstruction errors in peak and average flow contrasts were
33.2% and 31.0% larger than those reconstructed without
noise [FIGS. 25(c) and 25(d)]. Apparently, adding noise
reduced reconstruction accuracies in recovery of the
anomaly. However, the major conclusions drawn herein are
still valid.
A Priori Knowledge of Anomaly Location and Volume
Improved Flow Contrast Reconstruction in Simulations
FIG. 26 demonstrates the improvements in the reconstruc
tion of BFI contrasts using a priori knowledge of tumor
location and volume in DCT image reconstruction. The top
[FIGS. 26(a)-26(e)] and bottom [FIGS. 26(f)-26(j)] panels
show the reconstructed results when the anomaly is at the
central depth of 7 and 15 mm beneath the surface, respec
tively. In each panel, image results without/with a priori
information and without/with noise are plotted, respectively.
The transect plots [FIGS. 26(e) and 26(j)] show the BFI
distributions across the anomaly. The reconstruction accu
racies in BFI contrasts were significantly improved when a
priori knowledge of anomaly structural information was
applied on data with and without noise. The peak/average
BFI contrast errors were only 0.1%/4% (without noise) and
12.3%/12.3% (with noise), respectively, when using a priori
structural information for the anomaly located in the sensi
tivity region ofdiffuse light [i.e., at the central location of7
mm, FIG. 26(e)]. The BFI contrast improvement at the
deeper central depth of 15 mm was also remarkable [FIG.
26(j)].
High Blood Flow Contrasts were Observed in Human
Breast Tumors
Two patients with low-grade carcinomas were imaged
with our ncDCT system [FIGS. 27(b), 27(c), 27(e), and
27(1)]. The first patient (Pl) was a 59-year-old female who
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had ductal papilloma and low-grade adenocarcinoma in situ.
According to the ultrasound imaging [FIG. 27(a)], the lesion
with the dimension of 10.2x6.65 mm2 was located at 19.2
mm beneath the skin surface. For the comparison of ultra
sound and ncDCT results, the cross-section view of tumor
flow contrast image through the ultrasound imaging plane
(along the line of ultrasound transducer) and across the
overlapped two ncDCT sources (Sl and S2) is presented in
the reconstructed 3-D image [FIG. 29(b)]. The dimension of
the reconstructed tumor by ncDCT with the FWHM thresh
old was approximately 15.lx5.8 mm2 [FIG. 27(c)], which
matched the ultrasound image [FIG. 29(a)]. However, the
reconstructed tumor central location was 10.8 mm beneath
the breast surface, which differed from the ultrasound image
result (19.2 mm). The peak and average tumor blood flow
contrasts were 8.3-fold and 5.9-fold, respectively. Note that
measurement noise caused some artifacts with µa' 'a1(r, -i:)
lower than static µa(r, -i:) in the region bordering the recon
structed tumor, leading to some negative flow values.
The second patient (P2) was a 49-year-old female, who
had an a-typical ductal hyperplasia and low-grade carcinoma
in situ. Ultrasound images [FIG. 27(d)] show that the lesion
centroid was located at 13.3 mm beneath the skin surface
with the dimension of 8.5x3.5 mm2. Our ncDCT imaging
results show a clear large tumor lesion with two small
suspicious artificial anomalies [FIG. 27(e)]. The dimension
of the reconstructed large tumor was approximately 12.3x
5.1 mm 2 [FIG. 27(1)] and its central depth was 12.4 mm
beneath the breast surface, which fairly matched the ultra
sound imaging result. The peak and average blood flow
contrasts were 14.0-fold and 10.6-fold, respectively. Arti
facts with negative flow values were also observed in the
region bordering the reconstructed tumor.
The in vivo imaging results are consistent with our
computer simulation results (in that the tumor central location can be accurately recovered when the tumor locates
within the sensitive region of diffuse light.
Discussion and Conclusions
Since increased angiogenesis in breast tumor is com
monly associated with blood flow increase, imaging of
blood flow distribution in breast tissue is of great importance
for tumor detection.8 The recently developed ncDCT in our
laboratory provides a unique imaging tool for noncontact
detection of tumor blood flow contrasts.2 1 We have previ
ously demonstrated the ability of ncDCT for imaging blood
flow contrast in tissue phantoms with a simple semi-infinite
geometry.2 1 The remaining challenge of applying ncDCT for
breast tumor imaging includes translating the FEM-based
imaging algorithm to breast-shaped geometry and handling
potential problems arising from the in vivo measurements.
The goal of this study is to demonstrate the feasibility and
evaluate the accuracy of ncDCT in detecting breast tumors.
Computer simulations were used to investigate the origins
of flow reconstruction discrepancies. From the simulations,
we observed similar reconstruction accuracies in blood flow
contrasts and tumor central locations with slab-shaped and
breast-shaped boundaries (see FIG. 23 and Table 3), indi
cating the ability of ncDCT for reconstructing tumor flow
contrast in human breast with irregular geometry. Further
simulations on breast-shaped geometry evaluated reconstruction accuracies when tumors had different flow con
trasts and located at different depths. The results suggested
that the reconstructed tumor location and flow contrasts
were more accurate when the tumor volume was within the
sensitive region of diffuse light (see FIG. 24). Based on
photon diffuse theory, the penetration depth of diffuse light
is - 1h of the S-D separation.35 03 8039 The largest S-D sepa-
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ration of ncDCT was 30 mm, allowing for a penetration
depth up to -15 mm. As such, it was not surprising that the
reconstruction errors increased as the tumor center located at
a depth deeper than 10 mm. The S-D separation (associated
with light penetration depth) and SNR are two inter-related
parameters that affect the utility of ncDCT. Future study
should explore using source fibers with larger diameter to
deliver greater light intensity for promoting the SNR and
penetration depth.
In contrast to the recovery of tumor location, the reconstruction of tumor blood flow contrasts was more compli
cated. The reconstructed peak BFis were overestimated
when the tumor located closer to the breast surface and
underestimated when the tumor located out of the sensitive
region of diffuse light [see FIG. 24(c)]. By contrast, the
reconstructed average BFis were consistently underesti
mated. These observations are similar to those in DOT for
reconstruction of tumor absorption contrasts.44•45 It is
known from the DOT practice that imaging sensitivity is
higher at the shallow region beneath tissue surface.46 Therefore, the reconstructed peak BFI from a single node close to
the tissue surface tends to be overestimated.
However, most of the reconstructed BFis from the tumor
node are prone to be underestimated due to the nature of
inverse problem. Since the number of boundary data (S-D
pairs) in ncDCT is much smaller than the unknowns to be
solved (i.e., BFis at all mesh nodes), the inverse problem is
unstable,47 leading to the underestimation.44 In addition,
according to the definition of µatotal(r, -i:)=µa(r)+µad(r, -i:), BFI
reconstruction errors come from both "static" and
"dynamic" absorption coefficients. Therefore, dynamic flow
contrast errors may be further enlarged by attributing all
reconstruction errors of µatotal(r, -i:) to dynamic µad(r, -i:)
while ignoring static errors of µjr).
Similar to our previous findings,2 1 the relative changes of
tumor flow contrasts can be accurately reconstructed in a
large range of flow contrast variations [see FIGS. 24(d) and
24(e)]. The observed linear relationships with a slope of
close to "1" indicate the ability of ncDCT to capture tumor
blood flow changes, which can be potentially used to lon
gitudinally monitor tumor hemodynamic responses to inter
ventions.
As expected, adding noise reduced the reconstruction
accuracies (see FIG. 25). However, tumors can still be
reconstructed clearly from the boundary data with noise (see
FIG. 25), indicating the feasibility of ncDCT for in vivo
breast tumor detection. More importantly, adding a priori
knowledge of the tumor volume and location improved
significantly reconstruction accuracy (see FIG. 26), which
agrees with previous observations in DOT. 37•40•42 The
results from the two patients with low-grade carcinoma
showed higher blood flow contrasts in the tumor regions
compared to the surrounding tissues (see FIG. 27). The
reconstructed positions of the two tumors on the x-y plane
[see FIGS. 27(c) and 27(1)] agreed well with ultrasound
imaging results [see FIGS. 27(a) and 27(d)]. The recon
structed tumor central depth from the second patient (P2)
also matched the ultrasound image. For the first patient (Pl),
however, the reconstructed tumor central depth was at 10.8
mm beneath the breast surface, which did not match the
ultrasound finding (19.2 mm). This was likely due to deep
location of the tumor (Pl), which was beyond the sensitive
depth of diffuse light detected by our current system. To
confirm this, we conducted computer simulations with the
same location of tumor and similar level of measurement
noise, and we found that the reconstructed tumor located at
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-8.5 mm beneath the breast surface (data are not shown).
The simulation result agrees well with our in vivo measure
ment result.
Due to the difficulty of coregistering the 2-D ultrasound
image and 3-D ncDCT image, it was not possible in this
study to apply the a priori structural knowledge of tumors for
improving the accuracy of image reconstruction in patients.
Future study may utilize 3-D anatomical imaging modali
ties, such as MRI or CT, to obtain accurate priori structural
information of the tumor.
The average tumor-to-normal flow contrasts of 5.9- and
10.6-fold observed from the two carcinomas are comparable
to previously reported flow contrasts of 2- to 10-fold in
breast tumors detected by DCS.10· u It should be noted that
the tumor flow contrasts quantified previously by DCS may
be underestimated due to the partial volume effect by the
healthy tissues surrounding the tumor. In addition, the
potential crosstalk between µa, µ;, and BFI may also result
in over- or underestimation of blood flow contrasts in both
a
DCS and ncDCT.33035 According to the definition of µatot z,
µa, µ), and aDB variations cannot be completely separated
unless they are independently measured. When assuming
homogeneous µa and µ) over the entire breast, the realistic
heterogeneous µa and µ; across the tumor can generate
errors in tumor BFI contrasts. To overcome this limitation,
a separate instrument enabling 3-D imaging of µa and µ;
distributions in the breast is needed (e.g., a frequency
domain or time-resolved DOT).16•48-5 0
In conclusion, this reports the first flow image reconstruc
tion results in human breast tumors using a novel ncDCT
system. Results from computer simulations suggest that
relatively high accuracy can be achieved when the entire
tumor was within the sensitive region of diffuse light. Image
reconstruction with a priori knowledge of the tumor volume
and location can significantly improve the accuracy in
recovery of tumor blood flow contrasts. In vivo imaging
results from the two breast carcinomas show higher blood
flow contrasts in the tumor regions compared to the sur
rounding tissues, which are comparable with previous find
ings. The noncontact design of the ncDCT system has the
potential to be used for imaging blood flow distributions in
soft and vulnerable tissues without distorting tissue hemo
dynamics.
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Ex. 5: Speckle Contrast Diffuse Correlation
Tomography of Complex Turbid Medium Flow
Near-infrared (NIR) light enables the deep tissue inves
tigation of microvascular hemodynamics.1•2 Blood flow is
one such available observable promoting a wealth of physi
ological insight both individually and in combination with
other metrics. Diffuse correlation spectroscopy (DCS) and,
to a lesser extent, tomography (DCT) have received interest
over the past two decades as noninvasive methods for blood
flow recovery.3•4 In typical DCS implementations, the tem
poral fluctuations in individual speckles are measured by
avalanche photodiodes (APDs) coupled to independent opti
cal fibers.
These impose a physical and monetary overhead limiting
the potential sampling density and temporal resolution. In
our previous work, we extended DCS into a noncontact
lens-based system succeeded by noncontact DCT (ncDCT)
within a finite element method (FEM) framework.1•5 These
studies provided desirable operational attributes, especially
the elimination of hemodynamic alterations due to contact
compression and the ability to incorporate arbitrary tissue
boundaries and compositions. Moreover, our FEM recon
struction method is based on readily available open source
software for seamless integration of geometries and inver
sion algorithm techniques.6 The mechanical scanning of an
optical fiber array in ncDCT to cover a region of interest
(ROI) provides one solution to increasing sampling density
and reducing cost, but increases measurement duration and
may introduce motion artifacts. Another solution we outline
here, recruitment of charge-coupled device (CCD) detection,
promotes advantages including increased sampling density,
decreased sampling times and equipment overhead, and
geometry extraction potential. CCD detection has frequently
been utilized successfully in other flow monitoring tech
niques such as laser speckle contrast imaging.7 This modal
ity applies a wide-field illuminating source to enable rapid
collection of two-dimensional images depicting spatial ves
sel flow variations on superficial tissues. There have been a
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few recent advancements toward blood flow monitoring in
deep tissue with NIR point-source illumination and CCD
detection. Diffuse speckle contrast analysis and speckle
contrast optical spectroscopy approach the problem by using
the relationship between a speckle contrast parameter and
DCS theory.8' Speckle contrast optical tomography (SCOT)
extends the concept using an analytical Born approximation
in the inverse problem on transmission based measurement
of parallel-plane tissue phantoms.10 We move forward from
these studies in the direction of reflectance tomographic
imaging by developing a robust technique combining the
benefits of CCD detection and our FEM based DCT flow
reconstruction. In contrast to SCOT which formulates the
inverse problem with a direct analytical relationship
between the speckle contrast and mean-square displacement
of moving scatterers, we simplify the process by converting
the speckle contrast to boundary flow indices and retaining
our leverage of FEM-based DOT reconstruction advance
ments. Specifically, in this study we are able to take advan
tage of the nonlinear iterative algorithms, finite-element
support functions, data filtering, and the many features
included in the modified NIRFAST for DCT.5 This is due to
the formal similarity between DOT and DCT as outlined in
our previous publication.5 This unique method, termed
speckle contrast DCT (scDCT), facilitates three-dimensional
(3D) reflectance flow contrast imaging of complex turbid
media. As this technique promotes incorporation of both
heterogeneous optical properties and arbitrary tissue bound
aries, scDCT can utilize highly representative sample char
acteristics in the recovery of accurate flow data. We apply
this scDCT technique on a reflectance-based measurement
which more adequately represents the situation encountered
in larger subjects such as humans where transmission is not
practical in most cases (due to the limited penetration depth
of light), enhancing translatability. A smear correction algarithm is also incorporated in this study to resolve the
influences on data uniquely incurred when using frame
transfer CCDs with the point-source illumination and reflec
tance setup.
Methods and Materials
As shown in FIG. S(a), the scDCT equipment and experi
mental setup involve a 785 nm long coherence laser (coher
ence length>5 m, CrystaLaser, NV) to emit photons into the
sample. A fiber optic switch (VX500, Dicon, CA) with
fourchannel outputs delivered photons to four multimode
optical fibers (FT200UMT, Thorlabs, NJ) individually. The
fibers [Sl-S4 in FIG. S(b)] were located 1.5 cm from the
field of view (FOY) edge centers. An electron-multiplying
CCD (EMCCD; Cascade lK, Photometrics, AZ) with a
zoom lens (Zoom 7000, Navitar, N.Y.) aligned concentri
cally to the FOY detected the speckle patterns due to the
diffused light. The focal length of the image lens was 35 mm,
making the focal plane on the surface of the liquid phantom.
An F number of 8 was chosen to ensure the speckle size
satisfied the Nyquist sampling criteria.11
The application of DCS theory was applied as discussed
herein. Reconstructions of the combined term, µa(r)+µad(r,
-i:), are then carried out in NIRFAST using the "Standard"
options for a single wavelength and continuous-wave appli
cation. A median filter built into NIRFAST is used for
phantom test reconstructions as it assists in stabilizing
inherent experimental noise. This is because in real mea
surements the inverse problem is likely to generate odd
solutions in a few nodes which may not be encountered with
ideal simulation.5 ' The median filter offers six-level
smoothing from none to high (0-5) and we select level 2 in
this study. The inverse problem is set up using modified-
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Tikhonov regularization with minimization with respect to
optical properties and a biconjugate gradient stabilized itera
tive inversion scheme for Jacobian construction, as imple
mented in NIRFAST. The BFis are then extracted from the
reconstructed combined absorption coefficient using its defi
nition above.
The speckle contrast with shot and dark correction were
performed as discussed herein.
For physical experimentation, a liquid phantom provided
a homogeneous tissue-like model by a mixture of distilled
water, India ink (Black India, M A), and Intralipid (Fresenius
Kabi, Sweden).15 The property of real tissue was mimicked
by setting µa=0.05 cm-1, µ's=7.0 cm-1, and DB=lxl0-8
cm2/s (assumed15). A cube-shaped solid phantom (µa=0.05
cm-1, µ1 =7.0 cm-1, and aDB, was measured by DCS to be
about three orders of magnitude lower than the liquid
background) of carbon black, titanium dioxide, silicone with
7 mm side length was submerged to a 2 mm depth beneath
the surface of the FOY center.
Results and Discussion
During both heterogeneity presence and absence experi
ments, the scDCT measurement protocol consisted of
speckle contrast recovery over the liquid surface in a
sequential manner for each of the four sources. For each
source, 30 frames were acquired with an exposure time of 2
ms and frame rate of 8 frames/s. We defined 9x9 detectors
centered in the FOY over 1.0xl.O cm [FIG. S(b)] surround
ing the target surface. The resulting S-D separations were all
1.0-2.0 cm with 1.25 mm distance between detectors. Each
detector (0.42x0.42 mm) included 3x3 windows and each
window contained 7x7 pixels (8 µm pixel size). Measured
speckle contrast was calculated per window and averaged
across those corresponding to their associated detector.
Localized speckle contrast averages were then calculated
along obtained frames. The homogeneous phantom was
measured with scDCT first in the manner just described,
followed by a standard DCS measurement for calibration
purposes. Practically, the optical constant � is not available
for measurement. A calibration factor was thus determined
which equals to the ratio between speckle contrasts from
scDCT and those calculated using Eq. (2) with the semi
infinite CDE analytical solution for gl along with DCS
(� =0.5) measured BFI on the homogeneous phantom.
FIG. 28(a) illustrates the intensity distribution with source
S2 on the homogeneous phantom. FIG. 28(b) shows the
distribution after desmearing, demonstrating a normal pre
sentation for point-source intensity. To quantify the des
mearing influence, we consider an array of detectors defined
along the center row in line with the source location as
shown relative to S2 in FIG. 28(a). The S-D ranges from 1.0
to 2.0 cm. For each remaining source the detectors are
defined similarly, but with different orientation based on the
source location. The measured K for such detectors and each
source with and without desmearing is shown in FIG. 29(a),
along with the calculated K. To refine this depiction, we
increased effective detectors along the center row to 21 [see
the ROI and dots in FIG. 29(a)] while defining them the
same way as done elsewhere in the experimentation.
It can be seen that the desmeared K correlates with the
calculation. The region of usable speckle contrast without
desmearing is obviously limited with S2 most noticeably
impacted. This is due to our system configuration in which
frame transfer occurs in the direction from S2 to S4. The DB
value across the center row of detectors is shown in FIG.
29(b). The DB value achieved from DCS at 2.0 cm S-D
separation was 1.28xl0- 8 cm2/s. The independently aver
aged DB for Sl-S4 at the 21 detectors were (1.19±0.05)x
5
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10-s cm2/s, (1.18±0.08)x10-8 cm2/s, (1.17±0.06)x10-8 cm2/
s, and (1.13±0.06)x10-8 cm2/s. These are in good agreement
(within 12%) with the standard DCS measurement. The
comparison of K distributions measured from Sl on the
homogeneous and heterogeneous phantoms is shown in FIG.
30.
Next, we measured speckle contrast in the phantom with
heterogeneity. The corresponding boundary BFis were com
bined with the BFI obtained from the homogeneous phan
tom measurements for image reconstructions. We used a
finite element mesh [dimension(mm): 60(H)x60(W )x30(D)]
centered at (0,0,15) with a 3 mm node distance.5 The mesh
was refined in the known region of heterogeneity to improve
detection resolution while not overwhelmingly increasing
the number of nodes. Refinement was within a 15 mm radius
(e.g., inclusive of five elements) centered from (0,0,30) to a
1.5 mm node distance (total nodes: 10 307) using ANSYSR
( ANSYS, PA). The relative blood flow, rBF, is used to
denote the ratio of phantom with heterogeneity to homoge
neous phantom aDB 's. As presented in our previous work, 5
the algorithm based on an open software package NIR
FAST6 was used to reconstruct rBF in 3D. The reconstructed
image from homogeneous phantom and heterogeneous
phantom is shown in FIGS. 3l(a) and 31(b). A reconstructed
heterogeneity was clearly recognizable from the overlaid
cross-sections compared between the two images. FIG.
3l(c) shows cross sectional views of the heterogeneity
extracted by half max contrast threshold criteria. The aver
aged heterogeneity rBF was 0.38 with center (0.0, -0.1,
25.0) close to the actual center (0, 0, 24.5). Reconstructed
heterogeneity side length was 7.2 mm with dimensions that
were accurate compared to the true solid phantom. We
likewise simulated the phantom experiment by computer
using identical parameters. The region with heterogeneity
extracted by half max contrast threshold is shown in FIG.
31(d). The reconstructed heterogeneity averaged rBF was
0.37 with center (-0.1, 0.0, 24.0), similar to phantom results
(averaged rBF within 3% of phantom test results). Corre
sponding 3D flow distributions were also similar to the
phantom experiment [FIG. 31(b)] and hence are not shown.
We also performed two simulations with off-center loca
tions, but otherwise similar setup, of the heterogeneity and
found the reconstructed center and side length in agreement
with the expectation.
In this study, an exposure time of 2 ms was selected to
achieve a good contrast to noise ratio.16 The reconstruction
and boundary data parameters of delay time t and window
size used herein have been discussed in detail elsewhere.5•11
We acknowledge that static scatterer contributions can
degrade the current model. Ideally, recovered rBF would be
zero. However, we only sought to validate 3D flow contrast
detection using our new scDCT method rather than optimize
flow recovery accuracy, and we produced sufficient contrast
to identify and characterize the anomalous presence. The
agreement between scDCT and DCS on a homogeneous
phantom and between simulation and phantom in heteroge
neity detection supports success. Furthermore, multiple two
dimensional S-D pairs provided by the CCD omit the probe
scanning in ncDCT, 5 and thus significantly improve the
spatial and temporal resolution. In addition, due to decreasing signal with increased S-D separation using a point
source we were limited to at most 2.2 cm after noise
correction. Nevertheless, this S-D separation is still capable
of probing tissues -1 cm depth. We also note that although
the FEM framework allows incorporating complex heterogeneities and boundaries, we chose to exemplify our tech
nique in a straightforward setup.
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Further difficulties may be encountered when extending
scDCT to real complex media. For example, surface curva
ture may result in modified light distributions and S-D
separations potentially reducing the accuracy and reliability
of reconstructed flow contrasts. These issues are beyond the
scope of the current paper, but can be addressed in the future
through computer simulations, possible free-space correc
tions, 1 7 and telecentric zoom lens incorporation.18•19
Conclusions
We reported a cost-effective CCD-based reflectance 3D
flow imaging system from laser speckle contrast with four
target-contacted fibers serving as point sources. Beyond
dark and shot noise corrections, we successfully incorpo
rated an additional desmearing algorithm. This correction
was found to be imperative for reflectance applications using
a point source to obtain accurate deep tissue speckle con
trast.
Flow contrast was extracted using the relationship
between a correlation diffusion equation solution and the
speckle contrast. A FEM-based DCT framework was
employed to reconstruct spatially distributed blood flow.
This system was validated using a reflectance-based mea
surement on a liquid phantom with an internally placed
heterogeneity. Compared to our previous ncDCT design, 5
this system demonstrated potential for fast and dense bound
ary data acquisition and deep tissue hemodynamics tomog
raphy translating directly to human studies (e.g., burn/
ulcerous tissue flow detection).
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Ex. 6: nc_scDCT Test in Tissue Phantom and
Human Forearm
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The fully noncontact speckle contrast diffuse correlation
tomography nc_scDCT system integrated with a crossed
pair of polarizers (FIG. 32(a)) was tested in the homogenous
tissue phantom with source and detectors pattern in FIG.
32(b). FIG. 32(c) suggests the reflectance nc_scDCT can
produce homogenous flow index in homogenous phantom.
The spectroscopic version of nc_scDCT system has been
tested on a human forearm. Protocol included 3-minute
baseline, 4-minute arterial occlusion and 3-minute recovery.
Flow index of each point were normalized to the mean value
of the baseline. FIG. 33(a) shows the experimental setup.
FIG. 33(b) shows the relative blood flow (rBF) of four S-D
distances (3 mm, 6 mm, 10 mm, 14 mm).
The nc_scDCT system integrated with Galva mirror was
tested on liquid tissue phantom. FIG. 34(a) shows the
pattern of sources and detectors; 16 sources and 361 detec
tors were evenly distributed in an ROI of 3.6 cm2. A
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pump-connected 6 mm diameter cylindrical tube anomaly
3. The method of claim 1, wherein the detector array
comprises a two-dimensional (2-D) array ofavalanche pho
was filled with liquid and small pieces ofsolid phantom, and
todiodes.
was placed 2 mm beneath the liquid surface. The pump
4. The method of claim 1, wherein the imaging probe is
speed was set as 60 ml/min. The CCD camera captures
affixed to a motorized stage such that the probe can be
image at each source position at 10 ms exposure time. FIG.
systematically and automatically moved across a region of
34b shows the reconstructed heterogeneity anomaly, which
interest of the tissue.
agrees with the setup. To the best of our knowledge, this is
5. The method of claim 1, wherein the probe is focused
the first 3-D flow image generated by a reflectance
through a wound, surgical opening, or a tissue flap within the
nc_scDCT.
The foregoing has been presented for purposes of illus 10 subject.
6. The method of claim 1, wherein the 3-D image is
tration and description. It is not intended to be exhaustive or
reconstructed through a system that applies a finite-element
to limit the embodiments to the precise form disclosed.
method from the measured data set.
Obvious modifications and variations are possible in light of
7. An optical method for 3-D imaging of blood flow
the above teachings. All such modifications and variations
are within the scope of the appended claims when inter 15 distribution in deep tissue of up to approximately 1.5 cm
with an arbitrary tissue geometry comprising:
preted in accordance with the breadth to which they are
applying near-infrared light through source fibers to bor
fairly, legally and equitably entitled. All documents refer
ders of a region of interest of a tissue of a subject;
enced herein including patents, patent applications and
detecting the near-infrared diffused light through an optijournal articles and hereby incorporated by reference in their
cal lens coupled to a charge-coupled-device (CCD),
entirety.
20
wherein adjustable optical zoom lenses provide a focal
We claim:
length and varied field of view such that the region of
1. An optical method for three-dimensional (3-D) reflec
interest is covered by the 2-D array of detectors pro
tance imaging ofblood flow distribution in deep tissue ofup
vided by the CCD; and,
to about 1.5 cm with an arbitrary tissue geometry compris
constructing
an image based on a data set comprising
25
ing:
measured diffused near-infrared light from the 2-D
projecting/focusing an imaging probe comprising long
array of detectors provided by the CCD.
coherence laser sources and a detector array on a tissue
8. The method of claim 7, wherein the source fibers are
surface of a subject;
not in contact with the subject and further wherein the source
applying source beams of near-infrared light to the tissue
30 fibers are projected onto tissue surface using adjustable
through a set of optical lenses;
optical zoom lenses.
detecting diffused near-infrared light reflected from the
9. The method of claim 8, wherein the near infrared light
tissue surface through a second set of optical lenses by
is
projected
to the tissue by redirection using a Galva mirror.
a detector array and
10. The method of claim 7, wherein the charge-coupledconstructing a 3-D image based on a data set comprising
measured diffused near-infrared light from the detector 35 device along with the sources is connected to a motorized
stage such that the probe can be systematically moved across
array,
a region of interest of the tissue.
wherein the sources and the detector array are not in
11. The method of claim 7, wherein the image is con
physical contact with the tissue.
structed through a system that applies a finite-element2. The method of claim 1, wherein the detector array
comprises a one-dimensional (1-D) array of avalanche pho 40 method from the measured data set.
* * * * *
todiodes.

